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Abbreviations and definitions 
AE  Adverse event 
BA  Birth asphyxia 
Bpm  Beats per minute 
CISMAC Centre for Intervention Science in Maternal and Child Health 
CONSORT Consolidated Standards of Reporting Trials 
CRF  Case Report Form 
CI  Confidence interval 
ECG  Electro-cardiogram 
END  Early neonatal death 
ENAP  Every Newborn Action Plan 
ETT  Endotracheal Tube  
FM  Face-mask  
FMV  Face-mask ventilation 
FRC  Functional residual capacity 
GCP  Good Clinical Practice 
GLM  Generalized linear model 
HBB  Helping Babies Breathe   
HIE  Hypoxic-ischemic encephalopathy 
HR  Heart rate 
IDMC  Independent Data Monitoring Committee 
ILCOR International Liaison Committee on Resuscitation   
IQR  Interquartile range 
ITT  Intention-to-treat Analysis 
IVA  Instrumental Variable Analysis 
LM  Laryngeal mask 
LMA  Laryngeal Mask Airway   
LMIC  Low and middle-income country 
MAP  Mean airway pressure 
MDGs Millennium Development Goals 
MREC Mulago Research and Ethics Committee   
NE   Neonatal Encephalopathy 
NICU  Neonatal Intensive Care Unit 
NLS  Newborn Life Support 
NRP  Neonatal Resuscitation Program 
LS  Life Support   
NNT  Number of patients needed to treat (to prevent an outcome) 
PBF  Pulmonary blood flow  
PIP  Peak inspiratory pressure 
PP  Per protocol analysis 
PPV  Positive Pressure Ventilation   
QA  Quality Assurance   
RA  Research assistant 
RCN   Research Council of Norway 
RFM  Respiratory function monitor 
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RR  Relative risk 
s  seconds 
SAD  Supraglottic airway device 
SO2  Oxygen Saturation 
SpO2  Peripheral capillary oxygen saturation 
SAE  Severe Adverse Event 
SGA  Supraglottic Airway 
SDGs  Sustainable Development Goals  
SUSAR Suspected Unexpected Serious Adverse Reaction 
UN  United Nations 
UNICEF United Nations Children’s Emergency Fund 
Vte  Expired tidal volume 
Vti  Inspiratory tidal volume 
WHO  World Health Organization 
 
Definitions 
APGAR = backronym for Appearance, Pulse, Grimace, Activity and Respiration 
Perinatal Mortality (WHO) = number of stillbirths and deaths in the first week of 
life per 1,000 births. The perinatal period commences at 28 completed weeks (196 
days) of gestation, and ends 7 completed days after birth. 
Neonatal Mortality = newborn deaths within the first 28 days of life per 1000 live 
births  
Early Neonatal Mortality = newborn deaths within the first 7 days of life per 1000 
live births  
Birth asphyxia (WHO) = failure to establish respiration at birth 
MR SOPA: acronym for Mask Reposition, Suction, Open mouth, increase 
ventilation Pressure, Alternative airway 
Primary apnea = heart rate considered to be > 60 beats/min with compensated blood 
pressure  
Secondary apnea = progressive bradycardia < 60 beats/min and hypotension with 
final gasping  
Gestational age = defined as the best estimate of the newborn’s gestation in 
completed weeks based on the final estimate of gestation, irrespective of whether the 




Background: Approximately 2.5 million newborn infants died in the first month of 
life in 2019, despite the global rate being halved since 1990. The current newborn 
mortality rate in Sub-Saharan Africa is > 20 times higher than the average ratio of 1 
in 600 found in high-resource countries. Intrapartum-related death or birth asphyxia is 
the third leading cause of under-5 mortality and contributes significantly to global 
long-term developmental disability. Effective ventilation has the potential to reduce 
30% of these deaths. The laryngeal mask airway (LMA) is an airway tube that can be 
blindly inserted through the mouth of a non-breathing infant to form an airtight seal 
around the glottis. This device could improve neonatal resuscitation. 
Aim: To investigate whether midwives in low-resource settings could safely 
resuscitate newborns more effectively using LMA instead of a conventional face-
mask (FM). 
Methods: We conducted a preclinical manikin study and 2 randomized clinical trials 
in Uganda. Health workers involved in neonatal resuscitation were given brief 
training with LMA and FM. We recorded success rate and insertion times, leading to 
effective ventilation in the manikin. Participants rated the perceived efficiency of the 
devices using a 5-point scale. In the 2 clinical trials, midwives performing 
resuscitation after delivery of asphyxiated newborn infants were randomly assigned 
to ventilate with either LMA or FM. In the first trial, we collected data on ventilation 
time with a video monitor and heart rate (HR) with the NeoTap LS mHealth App. In 
the second trial, respiratory function was measured through a flow sensor, and HR 
data collected with a dry-electrode ECG. 
Results: In the preclinical trial, LMA was 100% successful on the first insertion. FM 
was significantly less effective in achieving effective positive pressure ventilation 
(PPV), and the failure rate at the first attempts was 28%. The perceived efficiency of 
the devices was superior for the LMA. In the first clinical trial, resuscitated infants 
started breathing on their own sooner in the LMA arm compared to FM. All 
resuscitations were effective in the LMA arm, and there were no side effects. In the 
second trial, mask leak (%) and tidal volume (ml/kg) were similar in both groups. The 
time needed to achieve heart rate >100 bpm in LMA was shorter than in the FM arm. 
There were no severe adverse events in either arm. 
Conclusion: LMA was more effective in establishing PPV in the manikin and user 
satisfaction was higher. LMA was more effective than FM in reducing the time to 
spontaneous breathing. LMA was associated with faster heart rate recovery compared 
to FM in newborns with bradycardia. Mask leaks and tidal volumes using LMA was 
similar to FMV. LMA seems to be a safe and effective device for newborn 
resuscitation in low-resource settings. 
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Thesis at a glance (paper I-III + annex) 
Participants 
Health workers performing newborn resuscitation (paper I) and infants in need of PPV with gestational age >34 and 
birth weight >2000 g (paper II-III, Annex) 
Paper I 25 participants 
Aim To compared the performance of personnel in in Uganda when using an LMA or a FM on a manikin 
Methods 
25 health workers involved in neonatal resuscitation were given brief training with LMA and FM. Success rate and 
insertion times leading to effective PPV were recorded. Participants rated the perceived efficiency of the devices using 
a five-point scale. 
Results 
LMA achieved a 100% success rate on first insertion. FM was significantly less effective in achieving effective PPV 
and the failure rates at the first attempts were 28%. The perceived efficiency of the devices was significantly superior 
for the LMA. 
Conclusions LMA was more effective than FM in establishing PPV in the manikin, and user satisfaction was higher. 
Paper II 49 participants (24 LMA, 25 FM) 
Aim To compare LMA to FM during neonatal resuscitation in a low-resource setting. 
Methods 
Prospective randomised clinical pilot trial conducted at the labor ward operating theatre in Uganda. After a brief 
training on LMA and FM use, infants with a birth weight >2000 g and requiring positive pressure ventilation at birth 
were randomised to resuscitation by LMA or FM. Resuscitations were video recorded. The primary outcome was time 
to spontaneous breathing. The secondary outcomes included conversion to other device and side effects. 
Results 
Time to spontaneous breathing was shorter in LMA arm than in FM arm. All resuscitations were effective in LMA 
arm, whereas 11 patients receiving FM were converted to LMA because response to FMV was unsatisfactory. There 
were no adverse effects. 
Conclusions 
LMA was more effective than FM in reducing time to spontaneous breathing. LMA seems to be safe and effective in 
clinical practice after a short training program. 
Paper III 46 participants (26 LMA, 26 FM) 
Aim 
To evaluate the respiratory function of an i-gel laryngeal mask airway (LMA) vs. a face mask (FM) in asphyxiated 
newborns resuscitated by midwives in a low-resource setting 
Methods 
This quasi-randomized trial evaluated respiratory monitoring during newborn resuscitation in Uganda. Same inclusion 
criteria as paper II. The primary outcome was difference in mask leak (%). The secondary outcomes included inspired 
(Vti) and expired (Vte) tidal volumes, and change in heart rate (HR). 
Results 
Mask leak was 39% in the LMA and 46% in the FM arms (p=0.32). Shorter time was needed to achieve heart rate 
>100 bpm in LMA with respect to FM arm. Three newborns in FM arm and none in i-gel arm were converted to the 
alternative device.
Conclusions 
Respiratory function was not different between LMA and FM in resuscitated newborns. LMA was associated with 
faster heart rate recovery compared to FM in newborns with bradycardia.  
Annex 1164 participants (trial protocol) 
Aim 
To investigate whether the use of a cuffless supraglottic airway device compared with face-mask ventilation during 
neonatal resuscitation can reduce mortality and morbidity in asphyxiated neonates. 
Methods 
A randomized phase III open-label superiority controlled clinical trial will be conducted in Uganda. Infants with a 
birth weight >2000 g and in need of PPV at birth will be randomised to LMA or FM. The primary outcome will be a 





























































































Our societies need to commit to the health of newborn. Facility-based interventions 
focused on the perinatal period are crucial if we want to improve survival.1 2 Life is 
most vulnerable when babies are not breathing at birth. Neonatal resuscitation is the 
art of saving those lives by acting quickly and efficiently. 
We have set ambitious goals both for the survival of mothers and babies, but are we 
on track? Despite all efforts, reduction of neonatal mortality in parts of Asia and Sub-
Saharan Africa, is occurring at only half the speed of maternal mortality or child 
mortality after the first month. Our efforts must also include a bold approach to 
innovations targeted at the most vulnerable populations. Developing, investigating, 
and implementing new technology for newborn health may help accelerate a 
reduction in neonatal mortality.3 
1.1 Neonatal mortality  
In 2015, after summarizing the Millennium Development Goal number 4 (MDG-4) of 
globally reducing by two-thirds the under-5 (years of age) mortality, it became 
evident that the neonatal mortality was not decreasing at the expected pace.4 The third 
leading cause of child mortality for the under-5s is intrapartum-related death, 
commonly referred to as birth asphyxia (BA). An estimated 5% or ~7 million of the 
140 million babies born in the world annually are not breathing at birth. Immediate 
resuscitation, including effective stimulation and ventilation, is necessary if these 
babies are to survive. 
The Demographic and Health Survey indicators from Uganda in 2017 show that 
under-5 mortality had decreased from 175/1000 in 1990 to 53/1000 in 2016.5 
Estimates indicate that 27/1000 newborn infants will not survive the first month. The 
situation has remained unchanged in Uganda (table 2) over this last decade despite 
the national roll-out of Helping Babies Breathe (HBB),5 6 a neonatal resuscitation 
training program for resource-limited settings.7 HBB implementation trials have 
demonstrated a reduction in fresh stillbirths and first-day neonatal mortality.8-10 
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The Sustainable Development Goal number 3 (SDG-3) re-emphasizes the need for 
accelerating the reduction of neonatal mortality; each country should try to achieve a 
neonatal mortality of < 12/1000 live births by 2030. As of 2018, 78 of 195 countries 
are still not on track. We need to radically improve existing newborn resuscitation 
programs if we wish to achieve this goal.11 Physicians, midwives, and other staff 
attending birth should have the knowledge and skills required to perform effective 
neonatal resuscitation.12 We also need to strengthen existing strategies with 
innovative tools that can be rapidly implemented if we are to reach the 12/1000 target 
of neonatal death by 2030. The commitment to reduce global neonatal mortality 
under the Sustainable Development Goals was pronounced in 2015 by United 
Nations Children’s Emergency Fund (UNICEF), Every Newborn Action Plan 
(ENAP), and the World Health Organization (WHO). ENAP has set up a particularly 
ambitious agenda to end all preventable newborn deaths by 2035.11 
1.2 Disease burden 
The latest estimates are that 717 000 deaths annually are caused by Birth Asphyxia 
(BA),13 making it globally the third leading cause of under-5 mortality.14 BA also 
contributes with 42 million disability-adjusted life years lost long-term to 
neurodevelopmental disability.15 Sequelae in survivors include developmental delay, 
cerebral palsy, cognitive impairment, epilepsy, hearing impairment and behavioral 
problems. Interventions are likely to have a positive impact on morbidity. Carlo et al. 
suggests that infants born in resource-limited rural communities who survived after 
bag and mask resuscitation had an 82% chance of having normal mental development 
(MDI > 85%) and an 84% chance of being free of severe disability when one year 
old.16 These are similar outcomes to non-resuscitated infants.  
1.3 Surviving birth 
Ersdal et al. have outlined a 3-phase prevention strategy17 that could reduce 
intrapartum-related adverse outcome:  
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1) Primary prevention: Delivery of high-quality obstetric and antenatal care that 
impacts early hypoxic insults to the fetus. This strategy has the greatest life-
saving potential, but relies on interventions in a complex health system.15 18-20 
2) Secondary prevention: Babies born with hypoxic insults who receive effective 
care at birth can survive with a high rate of successful outcomes. Such 
interventions can be achieved within a short time frame also in low-resource 
settings.9-11 21-27 
3) Tertiary prevention: Delivery of high-quality neonatal care can prevent further 
complications due to birth asphyxia, but are dependent on technologically 
advanced facility-based services requiring specialized staff.28-30 
The time horizon and expenses involved in improving health systems in low- and 
middle-income countries (LMIC) make secondary prevention highly relevant. Even 
in technologically advanced settings, the currently accepted standard of having 
skilled personal ready to perform neonatal resuscitation at every birth, took decades 
to become a reality. This reality has not yet been achieved in resource-limited 
settings.24 
The ENAP aims to reduce global neonatal death to < 10 per 1000 live births by 2035. 
The current rate is 2.3 per 1000 in Western Europe, 27 per 1000 live births in sub-
Saharan Africa and 18 per 1000 as the world average. Each year, 170 000 intrapartum 
related deaths could be saved by the widespread implementation of newborn 
resuscitation.31 National rollouts of HBB have emphasized the need to strengthen the 
knowledge and skills of birth attendants as well as teamwork.32 Implementation of 
HBB has improved rates of stillbirth and first-day survival.8 10 33 On-site, high 
frequency/low dose training has reduced 24-h mortality by 40%.8 Better delivery 
room management could delay death by birth asphyxia, that typically occurs after 3-5 
days. Studies reporting mortality through discharge or at 28 days show little change 
in overall mortality.10 34 Further efforts will be needed to translate new knowledge 
and skills into sustainable clinical practice.  
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1.4 From liquid to air 
Birth should be accompanied by the first breath and transition to independent life. 
Gas exchange in the newborn shifts from the placenta to the lungs soon after the 
umbilical cord is clamped and lung aeration must rapidly be achieved by clearance of 
any liquid-filled airways. Extra-uterine survival also involves major cardiovascular 
changes, redirecting much of the cardiac output towards the lungs.  
Fetal lungs develop in a liquid-filled distended state, critical for normal extra-uterine 
function.35 Breathing movements are initiated by the fetus at 11 weeks of gestation. 
Fetal respiration becomes more organized towards the end of pregnancy, reaching a 
rate of 30-70 /minute.36 The majority of babies (93%) successfully transition at birth 
and start breathing within 30 seconds.37 A switch of net secretion drives clearance of 
lung liquid to net absorption by an interaction of epinephrine, oxygen, 
glucocorticoids, and thyroid hormone in the distal lung epithelium.38 However, lung 
aeration is also associated with inspiration through generation of hydrostatic pressure 
and occurs more rapidly than can be achieved by fluid reabsorption alone.39 40 
Typically newborns clear their airways within 2-5 breaths.41 The pressure gradient 
generates a flow of lung liquid to tissues surrounding the alveoli, thereby increasing 
interstitial pressure.39 
Increased aeration triggers the activity of vasodilating agents and various mechanical 
effects that increase pulmonary blood flow (PBF).42 Left ventricular preload shifts 
from the umbilical venous return to pulmonary venous return. Systemic vascular 
resistance increases simultaneously to result in left-to-right flow through the ductus 
arteriosus, leading eventually to ductal closure.43 Mean oxygen saturation (SO2) in the 
fetus is 58%44 and can decrease to 30% during labor.45 Median peripheral oxygen 
saturation (SpO2) after birth reaches 68% at 1 minute, 92% at 5 min and 97% at 10 
min in term infants.46 Median heart rate (HR) at birth is <100 and stabilizes around 
160 after 3 min.47 48 At this point, most of the lung fluid is cleared from the alveoli; 
ventilation and blood flow are finally harmonized. 
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1.5 Failing to breathe 
The WHO defines BA as the clinical description of a newborn who “fails to initiate 
or maintain regular breathing at birth”.49 BA results of the impairments of gas 
exchange to the fetus or newborn during labor or directly after birth. Prenatal events, 
such as umbilical cord occlusion, placental dysfunction, uterine rupture, maternal 
hemodynamic compromise or infection, are the leading causes of perinatal 
asphyxia.50 51 The most severe cases result in fresh stillbirth (FSB) or early neonatal 
death (END). Postpartum events are most often caused by impaired cardiovascular 
transition, respiratory pathologies such as meconium aspiration syndrome (MAS), 
and airway obstruction by viscous secretions.  
The common underlying pathogenetic pathways of these events are hypoxemia, 
reduced oxygen pressure in the blood supply, and ischemia, reduced blood 
perfusion.52 Glucose is the other major driving force in energy production in the 
brain. Under anaerobic conditions, the generation of high energy phosphate 
compounds from glucose is markedly reduced, but it also results in lactate 
accumulation. A further cascade of events, including intracellular acidosis, formation 
of free oxygen radicals, glutamate, and nitric oxide, finally lead to cell death. In 
survivors, this leads to hypoxic-ischemic encephalopathy (HIE). HIE must be 
differentiated from other causes of neonatal encephalopathy (NE) such as sepsis, 
meningitis and metabolic disorders.53 
The initial response to BA is primary apnea (heart rate >60 beats/min and normal 
blood pressure) during which proper stimulation may result in the resumption of 
breathing (figure 1).54-56 If intervention is delayed or the infant fails to respond, an 
infant will progress to secondary apnea (heart rate <60 beats/min with hypotension). 
Continued stimulation will not help, and positive pressure ventilation (PPV) is 






Infants with profound bradycardia may be indistinguishable from fresh stillborn 
(FSB),57 and failure to identify and resuscitate these infants often leads to a 
misclassification of FSB, influencing global perinatal mortality estimates.58 
In 1952, Dr. Virginia Apgar introduced a scoring system that is a rapid method of 
assessing the clinical status of the newborn, providing a standardized assessment for 
infants after delivery and a mechanism to record fetal-to-neonatal transition.59-63 The 
Apgar score has 5 components: color, heart rate, reflexes, muscle tone, and 
respiration. Birth attendants give a score of 0, 1, or 2 to each component. The Apgar 
score is an assessment tool that cannot explain the etiology of the asphyxia but can 
give relevant information on neonatal outcome.64 The quality of the scoring can vary 
between observers.65 On a population basis, Apgar scores < 5 at 5 and 10 min 
correlate with an increased risk of cerebral palsy. An Apgar score at 5 min of 7 or 
more is associated to a favorable neurological outcome.60 66 67 
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1.6 Back to life 
And when Elisha came into the house, behold, the child was dead, and laid upon his bed... 
He went up, and lay upon the child, and put his mouth upon his mouth ... and the flesh of the 
child waxed warm... and the child sneezed seven times and opened his eyes. 
Old Testament 
The transition from a fluid-filled lung to an aerated lung of a breathing infant requires 
the establishment of functional residual capacity (FRC). The most effective practice 
remains controversial.32 Since times immemorial, it has been accepted that “life ends 
when the respiration ceases.” Different cultures have explored the importance of 
securing the airway with invasive devices since 4000 years ago.68 In 1754, Benjamin 
Pugh resuscitated infants using mouth to mouth and a coiled wire and soft leather 
endotracheal tube.69 In the mid-18th century, mouth-to-mouth resuscitation was 
recognized as effective,70 but fell out of favor after William Hunters designed a 
popular bellow for inflating the lungs.71 Immersion in a cold and hot water bath, and a 
variety of other harmful stimulation methods remained popular until the 1950s. 
Traditional birth attendants in rural Sub-Saharan Africa still blow air in the baby 
through a fetoscope - the instrument normally used for listening to fetal heart sounds - 
and mouth to mouth is practiced with WHO recommendations despite the risk of 
infection.49 72 However, the self-inflating bag, invented in 1958, finally became the 
standard of choice.  
In low-resource settings, face-mask ventilation must function without a source of 
oxygen or airflow. In 1998, WHO implemented the first practical guide for basic 
newborn resuscitation49 after surveys had shown that many institutions, including 
central hospitals, lacked proper resuscitation equipment and trained health personnel. 
The commission identified both recent and traditional practices, either non-beneficial 
or harmful for the infant, and recommended evidence-based methods. Preventive 
measures were also emphasized, such as preparation for birth, cleaning of equipment, 
prevention of hypothermia, proper hygiene, and essential newborn care. The basic 
resuscitation skills that focused on prompt delivery of PPV using a self-inflating bag 
and mask with room air remain valid today.73 In 2000, the International Liaison 
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Committee on Resuscitation (ILCOR) released the first consensus on science and 
treatment recommendations for neonatal resuscitation based on a systematic review 
of the quality of the evidence. The ILCOR consensus on neonatal resuscitation has 
been updated every 5 years and focuses mainly on resuscitation practices for 
resource-intensive settings.12 74 The first guideline targeting resource-constrained 
settings was published by WHO in 2012. It still focused on the core principles of 
newborn management that have remained unchanged for many decades. HBB is the 
initiative of the American Academy of Pediatrics, the WHO and other collaborative 
partners to develop a comprehensive educational training program based on the 
ILCOR consensus on science with treatment recommendations.7 75 HBB has been 
harmonized to the WHO guidelines and was updated to HBB second edition in 2018.7 
It has been implemented in more than 80 countries and is primarily targeted at 
midwives and auxiliary community-based birth attendants.76 A network of master 
trainers has instructed 500 000 health providers and the curriculum has been 
translated into twenty-seven languages.7 The HBB Action Plan emphasizes skills and 
team training. Non-crying babies should be stimulated and have their airways cleared 
by proper positioning and removal of secretions as necessary. Birth attendants should 
initiate PPV within 60 seconds, ‘the Golden Minute’. Advanced interventions such as 
alternative airways, chest compressions, volume expansion and provision of oxygen 
are not part of the HBB training.11 More research is needed to evaluate intermediate 
algorithms targeted at health facilities with mid-level providers or specialists found in 
urban facilities. The urban-rural gaps in facility birth are improving as a result of the 
2030 agenda77 and efforts should continue to develop hospital-specific neonatal 
emergency training programs. 
1.7 Conventional respiratory devices 
The UN established the Commission on Life-Saving Commodities in 2012. The 
commission’s goal was to promote and increase access to 13 life-saving commodities 
that could alleviate preventable causes of death during pregnancy, birth, and 
childhood. The essential commodities for basic neonatal resuscitation include the 
self-inflating bag and mask and suction devices.78 
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1.7.1 The self-inflating bag 
The self-inflating bag is the only device that can deliver PPV without an external 
source of air or oxygen; it is the favored system in low-resource settings. The typical 
bag size for neonates is 220-240 ml. The tidal volume required for term babies is 4-8 
ml/kg or approximately 13-25 ml per delivered breath. The reserve in volume can 
offset leakages, but may also deliver excessive volumes, especially in preterm babies. 
The level of Peak Inspiratory Pressure (PIP) is operator-dependent, with increased 
squeezing to the bag providing higher pressure. Self-inflating bags of reasonable 
quality are relatively cheap at 12-20 $.11  
Many self-inflating bags are single-use, but models such as the Laerdal Neonatalie 
provided with the HBB curriculum are reusable. Cleaning the devices, however, is 
costly and time-consuming, with improper routines leading to equipment failure.79 
Figure 2. Laerdal bag and two face‐masks of different sizes. (With kind permission 
from Laerdal Global Health) 
1.7.2 Face-mask ventilation (FMV) 
Resuscitation of infants using FMV (figure 2) is a well-accepted technique and 
“standard of care” in virtually all countries. The key features that will offer the best 
results are a round mask, with a soft rim that forms an adequate seal, and a reservoir 
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that delivers air.80 In our studies, a high-end Laerdal reusable silicone resuscitator 
provided PPV because it has a robust design, is easy to clean, and includes an 
effective silicone mask (figure 2).81 
Difficult mask ventilation occurs as a result of 2 primary mechanisms: an inadequate 
seal between the face and the mask, and upper airway collapse or obstruction.68 The 
MR. SOPA mnemonic was introduced by the Neonatal Resuscitation Program (NRP) 
to address these problems. Mask reposition and adjustment (MR) can minimize 
leakage. The suction of the airways (S) with a bulb or catheter deals with obstruction 
due to secretions. Opening the mouth (O) decreases airflow resistance. High lung 
compliance due to lung fluid may necessitate an increase in peak inspiratory pressure 
(P). Should these measures fail, the final step is the placement of an alternative 
airway (A) such as an endotracheal tube (ETT) or a laryngeal mask airway (LMA). 
1.7.3 Endotracheal tube (ETT) 
In case of ventilation failure with FMV, resuscitation should be followed by 
intubation with ETT.82 Placing an ETT is often challenging and requires a 
laryngoscope, and is usually fitted in the neonate by skilled anesthesiologists or 
neonatologists. There are several problems with endotracheal intubation that 
necessitate additional equipment on the resuscitation table, such as an active 
suctioning device. Cardiopulmonary failure may be secondary to perinatal asphyxia 
caused by improper tube placement.83 ETT placement may also result in more side 
effects (laryngospasm, bronchospasm, glottic and subglottic trauma) than LMA in 
pediatric surgical procedures.84 It is not considered a practical alternative airway for 
PPV in low-resource settings. 
1.8 Laryngeal mask airway (LMA) 
The laryngeal mask airway (LMA), figure 3, was designed by Archie Brain and first 
published in 1981. The aim of this radical innovation was to be more effective than 
the FM and less invasive than the ETT.85 LMA is both a generic term and a brand 
name. Other designations include laryngeal mask (LM), supraglottic airway device 
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(SAD) or supraglottic airway (SGA). LMA is the most widely recognized acronym 
and will be used in this thesis. 
Figure 3. Early prototype of the laryngeal mask. (With kind permission of Macmillan 
Press) 
In adults, anesthesiologists routinely use LMAs during surgical procedures. It has 
also gained popularity in pre-hospital resuscitations of adults in the hands of 
paramedics because it is easy to handle. New guidelines for neonatal resuscitation 
state that the laryngeal mask may be considered during resuscitation as an alternative 
to FM for PPV in newborns weighing >2000 g or delivered around or after 34 weeks 
of gestation.74 In the case of neonatal resuscitation, previous observational studies, 
and one quasi-randomized study have shown that the LMA facilitated effective PPV 
in most of the treated infants (range 95-99%).86 The potential advantages of using a 
LMA include the ease of insertion without a laryngoscope and minimal manipulation 
of the larynx.82 Staff can use the LMA with a standard self-inflatable bag or a T-piece 
resuscitator. The first generations of LMAs required skilled operators, making it 
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harder to get an effective seal for lower cadre (non-doctor) birth attendants. 





1.8.1 Conventional LMA 
A neonatal LMA is built around an elliptical airway tube that allows easy placement. 
The interface with the larynx consists of a pre-curved cuff for an effective seal. The 
user places the LMA blindly along the palate of the patient until resistance is felt, as 
the tip fits in the top of the esophagus. After placement, the user inflates the cuff with 
air or saline fluid according to the size of the patient and administers PPV. In the 
Democratic Republic of Congo, training insertion with cuffed supraglottic airways on 
neonatal manikins with midwives and physicians had a high success rate of 
insertion.87 
1.8.2 Uncuffed LMA: the i-gel 
Dr Muhammed A. Nasir invented the i-gel® uncuffed LMA (Intersurgical Ltd, 
Wokingham, Berkshire, UK) after 19 years of research. It was approved for clinical 
practice in 2007 and is widely used in general anesthesia and pre-hospital care.88 This 
single-use, latex-free LMA includes a unique cuffless design that fits tightly into the 
perilaryngeal framework. The interface is made of a soft, gel-like transparent 
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thermoplastic elastomer, which exerts a slight pressure on the pharyngolaryngeal 
structure and provides a seal without the need for an inflatable cuff89 (figure 5 and 6). 
Figure 5. The i‐gel and the face‐mask. (Photo: Thorkild Tylleskär) 
The smallest available i-gel is in size 1 and has been registered for use in neonates (2-
5 kg). However, the design is made to fit even small-for-gestational-age infants and 
preterm infants (1-2 kg). A 1470 g baby was successfully resuscitated with a size 1 i-
gel.90 The main advantage of the i-gel is ease of placement because of small size and 
precurved shape. I-gel reduced insertion time from 18 to 13 seconds compared to a 




Neonatal resuscitation research with uncuffed LMA has never been conducted, and 
any potential benefits remain unknown. The user-friendly design and innovative 
interface of the device could be particularly well suited for low-resource settings, 
were asphyxiated babies are often resuscitated by non-doctor staff.  
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2. Aim and objectives 
The aim of this thesis was to investigate if midwives in low-resource settings could 
resuscitate newborn more effectively using a laryngeal mask airway instead of a 
conventional face-mask. 
2.1 Specific objectives 
1. To explore in a phase 1 preclinical manikin study, the ventilation performance 
and efficacy perception of participants without previous skills in the use of 
laryngeal mask airway (LMA) compared to face-mask ventilation (FMV) in a 
model (paper I).  
2. To determine the effect of LMA on resuscitation time compared to FMV (paper 
II and III) including: 
 time to spontaneous breathing 
 ventilation time 
3. To assess if the LMA can be safely task-shifted to midwives in a low-income 
setting (paper II and III) by describing: 
 Adverse events 
 Outcome at 48 h 
 Neonatal encephalopathy 
 Admission to the neonatal unit 
 Assistance of a supervising physician 
 Need for cross-over to an alternative airway after failed ventilation 
4. To assess the physiological response of newborn receiving PPV with LMA 
compared to FMV (paper II and III) including: 
 heart rate 
 expiratory tidal volumes 
 mask leakage 
 positive inspiratory pressure 
 airway obstruction   
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3. Methods 
The clinical research in this thesis consists of a series of trials (table 1 and figure 7). 
The objective of phase II and III randomized controlled trials was to establish the 
efficacy and of a medical intervention. A cross-cutting theme in the phase III trial 
(Annex) has been the opportunity to address specific questions such as monitoring 



























3.1 Study setting and population 
We conducted the research in this thesis at the Department of Obstetrics and 
Gynecology, Mulago National Referral Hospital in Kampala, Uganda. We chose this 
site mainly because of a long-standing academic collaboration between Makerere 
University, the University of Bergen and the Karolinska Institutet. The studies were 
motivated by previous research conducted at the site, which showed a high 
prevalence of brain injuries after birth asphyxia51 92 93 and continued high rates of 
neonatal mortality (table 2), despite existing neonatal resuscitation training programs. 
Our local investigators were also experienced in data collection and the training of 
health staff.  
Table 2 Early childhood mortality rates 2002‐2016 in Uganda adapted from the 
demographic and health survey 2016 5 
Years  2002 ‐ 2006  2007 ‐ 2011  2012 ‐ 2016 
Neonatal mortality      24      28       27 
Post‐neonatal mortality a      45      25       16 
Infant mortality      69      53       43 
Mortality 1 ‐ 4 years     51      32       22 






For paper I and II, we carried out the study in 2013 at the Operating Theatre of the 
Department of Obstetrics and Gynecology at Mulago National Referral Hospital. 
Mulago hospital is the National Referral Hospital for Uganda and a Teaching 
Hospital for Makerere University College of Health Sciences with a total of 28,759 
total antenatal visits, 39,081 deliveries, and 11,120 postnatal visits in 2015. The 
neonatal special care unit has 42 cots, but cares for up to 110 infants. Mulago also 
serves as a general hospital for the Kampala metropolitan area, where the population 
is ~4.5 million. We performed both studies at the operating theatre where 15-30 
cesarean sections – most of them on an emergency basis – were performed daily. A 
staff of 12 doctors (obstetrics and anesthesiology) and 13 midwives participated in 
the duty roster. Midwives and doctors in the delivery suite monitored most of the 
fetal heart rate using fetoscopy and hand-held Doppler fetal monitors. Newborn 
resuscitation was mostly performed by midwives, rarely by doctors. All staff 
participating in the study had received basic newborn resuscitation training and had 
had clinical experience of ventilating newborns with a face-mask. None of the team 
had ever used neonatal LMA in the unit. Positive pressure ventilation was performed 
on an average of 2 babies a day after an emergency cesarean section. Each of the 2 
theaters had one basic resuscitation table without functional infant warmers. Oxygen 
(100%) could be delivered through nasal prongs after delivery in case of persistent 
cyanosis, generally without reliable pulse oximetry. The resuscitation equipment 
consisted of suction bulbs, self-inflating bags, and masks of varying sizes (all from 
Laerdal, Stavanger, Norway). Adequate equipment and skills for endotracheal 
intubation were rarely available. In cases of hypovolemia, intravenous fluids were 
delivered through peripheral intravenous lines. Embrace portable warmers were used 
to transport infants after resuscitation to the neonatal special care unit.  
The NeoSupra Trial (Annex I) was carried out at Kawempe referral hospital, ~12 km 
north of the city center (figure 7). The hospital opened in 2016 and houses the 
delivery units of the Department of Obstetrics and Gynecology of Mulago National 
Referral Hospital, during the construction of the new Mulago Specialized Women 
and Neonatal Hospital. The staff delivered 24,434 live babies in 2018. Newborns 
participating in the study were recruited from one resuscitation area in the delivery 
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suite and 2 resuscitation tables in the operating theatres. Three research assistants and 
one supervisor were present at any time in the resuscitation area. The resuscitation 
area had the same standardized equipment as in the previous study, but the study 
team also cleaned and disinfected the equipment according to the HBB guidelines. A 
total of 150 midwives and doctors participating in the obstetric care at the hospital 
and took part in the study. 
Paper III is a sub-study of the NeoSupra trial with detailed registration recorded on a 
limited number of infants included in the NeoSupra trial.  
3.2 Participants 
3.2.1 Paper I 
Doctors, nurses, and midwives involved in neonatal resuscitation at the Labor Ward 
Theatre at Mulago National Referral Hospital.  
3.2.2 Paper II-III and Annex 
Inborn infants fulfilling the following inclusion criteria were eligible to participate in 
the trials: gestational age >34 weeks by best obstetric estimate (last menstrual period 
or ultrasound scan), expected birth weight >2000 g, need for PPV at birth and written 
parental consent. Exclusion criteria included major malformations or stillbirth. 
3.3 Training 
3.3.1 Paper I-II 
A total of 25 participants working in the labor ward, including 12 doctors and 13 
midwives and nurses, participated in an “on-the-job” Helping Babies Breathe (HBB) 
refresher course, including a training module for the use of LMA. We reviewed the 
HBB action plan, including the steps of stimulation, suction, and ventilation. The 
LMA training lasted 10 min and included a short lecture, a description of the LMA 
and the handling of the device, the insertion technique, and corrective measures in 
cases of failed insertion/ventilation. The LMA was lubricated before insertion in the 
manikin study. Skills training for the use of LMA and FM were practiced on a 
36 
manikin model, the SimNewB Laerdal (Laerdal, Stavanger, Norway), which provides 
realistic airways with anatomically correct pharyngeal structures and good feedback 
with chest-rise when effective PPV is provided. Thread sealing tape was added at 
connection points of the airways to ensure a leak-free system. 
 
Figure 8. Neonatal resuscitation training. (Photo: Nicolas Pejovic) 
3.3.2 Paper III and Annex 
Two hundred and fifty midwives, doctors, and nurse-anesthetists involved in the care of 
neonates at Kawempe Hospital participated in a one-day modified HBB second edition 
course (figures 8 and 9), including a training module on the use of the LMA. Twenty-five 
participants and 5 facilitators participated in each session. Seven NeoNatalie inflatable 
manikins and 2 SimNewB high-fidelity manikin (both Laerdal manikin, Laerdal, 
Norway) were used to train the staff in the use of both devices (i-gel and FM). Facilitators 
used 2 newLifebox-R (Advanced Life Diagnostics, Weener, Germany) neonatal 
respiratory function monitor (RFM) at the skills training stations to improve the 
ventilation performance of the participants. The monitor provided feedback to the 
participants by displaying of airway leak (%), peak inspiratory pressure (cm H2O), the 
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tidal volumes (ml/kg), and respiratory rate. We practiced corrective measures, such as 
repositioning of the FM or LMA, careful increase of the inspiratory pressure and 
adjustment of the respiratory rate. All participants had to perform 3 successful ventilation 
sessions with each device (= resulting in an appropriate chest rise) before being certified 
to take part in the trial. Refresher courses and simulation sessions based on the HBB 




3.4 Randomization procedure 
3.4.1 Paper I 
Random assignment using sealed envelopes determined the order, starting with FM or 
LMA, in which participants ventilated the manikin. 
3.4.2 Paper II: 
We prepared a small opaque plastic container that concealed 25 white and 25 black 
toothpicks (figure 10). A study doctor randomly took a toothpick from the container 
at the beginning of each caesarean section. The color of the toothpick determined if 
FM or LMA would be placed on the resuscitation table. Should the baby need 
resuscitation and meet inclusion criteria, the toothpick was broken and discarded. If 
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not, the intact toothpick was placed back into the container. This randomization tool 
was proven to useful in a low-resource context with intermittent power cuts and 
limited space. This no frills approach could also be used in the broader context of 
emergency research, when time to randomization is critical. It also ensures a 




3.4.3 Paper III 
The design of the NeoSupra Trial posed particular challenges for the randomization 
process: 24/7 recruitment, resuscitations occurring in separate areas of the hospital 
and sometimes coinciding with each other. A day-by-day cluster randomization 
procedure was adopted so that all newborns enrolled on a particular day (representing 
a cluster) were randomized to the same treatment. An independent statistician 
prepared the randomization lists kept in sealed envelopes. A research assistant 
supervisor opened a new envelope each morning at 8.00 am and informed the 
midwives on duty of the assigned treatment. This method randomized daily groups of 
neonates rather than individual neonates. Sample size calculation took into account 
the clustering structure of the data.  
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Switch of device 
Midwives performing resuscitation were recommended to use the assigned device for 
at least 3 min before considering switching the ventilation option from FM to LMA 
or vice-versa.  
3.5 Equipment and data recording 
3.5.1 Video monitor 
We recorded all the resuscitations on video with a HD 1080P Black box AI-IP018 
camera (Shenzen Aishine Electronics Co. Ltd, China) attached to a magnetic mount 
on the 3 available resuscitation tables (figure 11). The field of view was centered on 
the infant and the hands of the staff. Data were collected each morning from the 
camera's memory card and transferred to 2 separate hard drives. This method allowed 
precise assessment of a) ventilation time, b) HR, c) any assistance given by the 
supervising physician, and d) any switch to an alternative device. Time from birth to 






3.5.2 NeoTap Life Support App 
Heart rate measurement is critical for the evaluation of the asphyxiated newborn but 
may be inaccurate in the delivery room.94-102 NeoTap Life Support (NeoTap LS) is a 
mHealth (mobile health) application that was designed by members of the research 
team (SM, NP) to measure neonatal heart rates. It was developed by the non-profit 
organization Tap4Life (Stockholm, Sweden) both as a research tool and clinical 
monitoring device for low-resource settings. A major feature of NeoTap LS (figure 
12) is a precise algorithm-based assessment of the HR.103 Research doctors used the 
NeoTap to collect HR data during resuscitation by listening to the heart with a 
stethoscope and simultaneously tapping the screen of a smartphone. This method 
allowed intermittent assessment of the HR during resuscitation with the output being 
visible on a video display. Research assistants and study doctors received phones 
preloaded with beta software versions during the trial preparation. Agile software 
development allowed us to continuously modify the design, interface, and features of 
NeoTap LS after user feedback and video analysis, which resulted in the integration 
of a package of additional features, such as:  
• Checklist for equipment 
• Resuscitation timer  
• Color-coded heart rate and breathing rate monitor  
• Fetal heart rate monitor 
• NeoPacer (acoustic and visual ventilation support) 
• Automated Apgar score calculation 
• Clinical tutorials 
• Referral decision support 
• Danger sign assessment 
• Free global download on Google Play and App Store 
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Dr Susanna Myrnerts-Höök collected data for additional sub-studies of the trial that 
will help us understand how this tool could improve the quality of newborn 
resuscitation. 
3.5.3 Electrocardiogram (ECG)  
A dry-electrodes ECG (NeoBeat Newborn Heart Meter, Laerdal Global Health, 
Stavanger Norway) was used to collect HR data48 104 (figure 13). When not in use, the 
unit rests on a mounted charging stand. The NeoBeat is placed on the chest of infants 
prior to ventilation and HR is obtained within a few seconds on a backlit display. The 







3.5.4 Respiratory function monitor 
Respiratory function monitoring (RFM) is rarely used in the delivery room but can be 
a useful tool for assessing the quality of ventilation of the newborn.104-115 The 
NewLifebox-R (Advanced Life Diagnostics, Weener, Germany) neonatal monitor 
(figure 14) was used for RFM. This compact unit is very accurate116 and can function 
autonomously for several hours (figure 14). A variable orifice pneumotachometer 
(Avea VarFlex Flow Transducer, Vyaire Medical, Yorba Linda, USA) measured 
airway pressure and flow between the self-inflating bag and the FM or LMA. The 
probe only added 0.7 mL dead-space to the system. The RFM integrated the 
pneumotachometer signals and displayed the inspired tidal volume (Vti) and expired 
tidal volume (Vte), leak (%) and peak inspiratory pressure (PIP). A separate monitor 





3.6 Data collection and management 
Research assistants and trial investigators collected the perinatal data on pre-coded 
case report forms (CRFs) bedside by consulting clinical charts and after interviewing 
mothers to the recruited participants after labor. Observations during resuscitation 
were timed with a stopwatch. Video review of the resuscitations provided additional 
resuscitation data and quality control of the interventions. Research doctors collected 
HR data. 
3.6.1 Paper I 
In this manikin study, health staff that participated in the training were asked to place 
each of the 2 devices (LMA and FM) on 3 consecutive occasions as they were timed 
with a stopwatch. The time to establish a chest rise on the manikin was recorded by a 
single unblinded observer from the moment when the FM/LMA was picked up. The 
success rate was determined by successful ventilation occurring within 30 seconds. A 
maximum of 2 new attempts was carried out in the case of failure. Participants 
evaluated the ease of application and ventilation on a five-point Likert scale: 1 for 
insufficient, 2 for sufficient, 3 for fair, 4 for good and 5 for excellent. Desirability 
bias was mitigated by informing participants of the aims of this comparative study 
after their involvement. Data was entered in an Excel database and analyzed using the 
statistical package STATISTICA, StatSoft version 6 (www.statsoft.com).  
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3.6.2 Paper II 
In this pilot clinical trial, data was collected and managed by a team consisting of 3 
investigators, 2 research assistants and 1 data entry manager. The research assistants 
collected the perinatal data on pre-coded case report forms (CRFs) bedside by 
consulting clinical charts and interviewing mothers to recruited participants after 
recovery from cesarean sections. Clinical outcome data of participants was collected 
on paper CRFs by both research assistants at 24 and 48 h. 
PPV with FM or LMA was initiated in the case of apnea and/or gasping at 1 min of 
birth. PPV was administered with a 230-mL silicon self-inflating bag with a pop-off 
valve limit at 40 cm H2O connected to a silicone, round-shaped FM (both Laerdal 
Medical, Stavanger, Norway). Health staff applied corrective measures according to 
the MR SOPA strategies in case of inadequate ventilation. PPV was continued until 
spontaneous breathing was established.  
All resuscitations were video recorded by a camera attached to a mount on the 
resuscitation table. Clare Lubulwa (CL), co-investigator and supervising physician 
collected HR data by auscultating the heart at set time intervals, using NeoTap LS on 
an android tablet. Data was collected after each resuscitation from the cameras 
memory card and transferred to 2 separate hard drives. Video review allowed precise 
assessment of time to spontaneous breathing, ventilation time, HR, assistance by 
supervising physician, and switch to an alternative device. Time from birth to the 
beginning of resuscitation was registered by a RA using a stopwatch. Data from 
resuscitation and paper CRFs was entered separately into an Excel database by 2 
investigators. Non-matching data was assessed after video review by a third 
investigator. The clean data set was entered separately and analyzed by the 
statistician (FC) using R V.3.2.2 software (R Foundation for Statistical Computing, 
Vienna, Austria).  
3.6.3 Paper III and Annex 
In the NeoSupra trial, data was collected and managed by a team consisting of 3 
investigators, 18 research assistants (Paper III and Annex) and 2 data entry managers. 
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Observations during resuscitation were timed with a stopwatch. Video review 
provided additional resuscitation data, including ventilation time, any assistance by 
supervising physician, any switch to an alternative device and any need for advanced 
resuscitation. Time from birth to the beginning of resuscitation was registered by a 
RA using a stopwatch. HR data was collected at the start of ventilation by placing the 
frame of the dry-electrode NeoBeat on the chest of a newborn infant not responding 
to stimulation. The RFM sensor was placed between the self-inflating bag and the 
device, and PPV delivered by the same principles as described above (paper III).  
The local trial manager and research assistant supervisor, reviewed the paper CRFs 
and resuscitation videos on a daily basis for quality control assurance. Weekly 
meetings were held with the research assistants (RA) to correct for inconsistency and 
missing information. Regular meetings were held with the RAs to maintain the 
quality of the data collection. RAs were retrained in cases of protocol violation. Data 
were doubly entered into Open Data Kit (ODK, https://opendatakit.org), an open-
source tool for mobile data collection (NeoSupra trial and Paper III) by the 2 data 
entry managers from the paper CRFs. Data-cleaning was performed by a co-
investigator and non-matching data corrected after review of the scanned CRFs. The 
clean data set was transferred to a statistical software package for analysis, with the 
data stored on an encrypted server that could only be accessed by the main 
investigators.  
3.7 Statistical analysis 
3.7.1 Paper I 
A convenience sample of staff participating in newborn resuscitation was included in 
the study, and no sample size was calculated. Each individual staff member consented 
to participate. 
Paired t-test, and unpaired t-tests were used to determine the difference between the 
LMA and FM regarding the success rate of insertion, mean time to successful 
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ventilation, perceived ease of insertion and perceived effectiveness of ventilation. 
p<0.05 was taken as significant.  
3.7.2 Paper II 
The sample size was determined in accordance with the only large study on this 
topic.86 We expected a longer time to spontaneous breathing with FM compared to 
LMA. Moreover, we estimated the time to spontaneous breathing to be longer in our 
sample because of delays in delivery and difficulties in assessing fetal distress at 
Mulago Hospital. Time to spontaneous breathing was modelled with gamma 
distribution as right-skewed data of duration. In accordance with local clinical 
observations and available information in a similar setting, we estimated a mean time 
to spontaneous breathing of 210 s. A sample size was estimated at 25 subjects in each 
arm with a power of 0.80. This sample size was also considered appropriate for a 
task-shifting trial emphasising safety aspects when involving midwives for the first 
time in advanced airway management. 
The Fisher’s exact test was used to compare categorical data between the 2 arms. 
Data were expressed in numbers and as percentages. The Mann-Whitney test was 
used to compare birth weight (expressed as median and IQR). Time to start of PPV, 
spontaneous breathing, and ventilation time were modeled with gamma distribution 
and the observed duration data were summarized as means and SDs. The effect of 
LMA and FM on duration data was assessed using a gamma model. HR data were 
collected at specific time intervals during resuscitations and expressed as mean and 
SD. The effect of the device on HR was determined by a linear mixed effect model 
accounting for the longitudinal structure of the data. p < 0.05 was considered 
significant.  
3.7.3 Paper III 
A sample size of 46 newborns (23 per arm) was required to have a 0.9 chance of 
detecting a mean difference of 20% (SD 20) in the primary outcome measure (mask 
leak during first 60 breaths) at a significant (p<0.05) level between the 2 arms. 
Continuous data were compared between the 2 arms using Student's t-test or Mann-
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Whitney test, as appropriate. Categorical data were compared between the 2 arms using 
Fisher’s test. Continuous data were expressed as mean and standard deviation (SD) or 
median and interquartile range (IQR), while categorical data were expressed in numbers 
and as percentages.  
We evaluated the HR measures over time with a random regression model, including arm, 
time and an interaction term arm*time. The tests were 2-sided, with p<0.05 being 
statistically significant.  
3.8 Ethical considerations 
All the individual staff members in the manikin study (paper I) consented to 
participate in the study. The trials in papers II, III and Annex were approved by the 
Institutional Review Board (IRB) of Mulago National Referral Hospital, Uganda, the 
Uganda National Council of Science and Technology, the Director-General from the 
Ministry of Health, Uganda and by the Regional Committee for Medical and Health 
Research Ethics in Norway, No 2013/2096 and 2017/989. 
3.8.1 The consent process 
In paper II, oral and written information was obtained from the mother and relatives 
upon maternal admission. A senior investigator was available on the wards to discuss 
any queries concerning the trial. Informed written consent was obtained prior to 
delivery by a parent or caregiver before admission to the operating room.  
In paper III and annex, a 2-tiered consent procedure was implemented in this trial 
after extensive discussions with the ethical review board. A recent study in the 
pediatric emergency department had also used a similar procedure.117 The provision 
of basic written and oral information about the trial was given from dedicated 
research assistants to all mothers that entered the labor ward. Oral consent was sought 
unless the mother was too ill or distressed. A senior investigator was available at any 
time to discuss further questions concerning the trial. A full written deferred consent 
that included all required elements of a regular consent was subsequently obtained 





3.8.2 Discontinuing resuscitation 
According to the ILCOR international consensus on neonatal resuscitation74 and 
Mulago Hospital neonatal resuscitation guidelines (figure 15), health staff was 






































































































10 min or no recovery of spontaneous breathing after 20 min, even if the heart rate 
was adequate. 
3.8.3 Safety and harms  
Standard operational procedures (SOPs) for detection and reporting of adverse events 
(AEs) and serious adverse events (SAEs) were implemented at the study site before 
the start of the trial. Compliance to the protocol and the neonatal resuscitation action 
plan were rehearsed during dry runs prior to the start of the trial. Baseline data from 
the hospital was recorded, and procedures discussed with staff and clinical heads of 
the departments of Obstetrics and Pediatrics. Safety measures included reporting of 
SAE in the case report forms (CRFs) used for data collection, and monitoring of the 
resuscitation area with video and detection of unexpected changes in the incidence of 
common neonatal complications. The research assistants participated in weekly audits 
aimed at improving the quality of clinical work and identification of possible SAEs. 
All SAEs, regardless of a suspected causal relationship with the intervention, were 
reported within 7 days to the Mulago Research and Ethics Committee (MREC) to 
guarantee the safety of the participants. Any Suspected Unexpected Serious Adverse 
Reactions (SUSARs) with or without a reasonably plausible causal relationship with 
the use of the LMA were also reported to the MREC. 
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4. Main findings 
4.1 Teaching ventilation with LMA in a manikin model 
The first study in this thesis compared the use of the LMA with FMV, the standard of 
care in low-resource settings. A manikin-based training module was integrated in an 
HBB refresher course. Twenty-five healthcare providers (12 doctors and 13 midwives 
and nurses) participated in the study. LMA was significantly better compared to the 
FM in establishing effective PPV (p<0.001) and had a 100% success rate in providing 









Success rate   n (%)  n (%)   
1st attempt   25 (100)   18 (72)   <0.001 
2nd attempt  25 (100)   23 (92)   <0.001 
3rd attempt   25 (100)   20 (80)   <0.001 
Mean time to successful ventilation  Mean ± SD   Mean ± SD   
1st attempt (seconds)   6.2 ±2.3   8.3± 4.7  0.18 
2nd attempt (seconds)   5.2 ±1.1   9.9± 14.1  0.68 
3rd attempt (seconds)  4.5 ± 1.0   6.6 ± 5.9  0.38 
Ease of application/ ventilation  Median ± SD   Median ± SD   
Score (one lowest, five highest)  4.7 ± 0.4   3.3 ± 0.8   <0.001 
51 
 
4.2 Task-shifting the use of LMA to midwives in low-resource settings 
At Mulago hospital, midwives with no experience of advanced airway management 
could learn to ventilate effectively a manikin after a 5 min training module. The user 
satisfaction on a 5-point Likert scale was 4.7 in the LMA compared to 3.3 with the 
FM (paper I). 
Two experienced study doctors supervised newborn resuscitations in this first task-
shifting trial involving midwives using LMA (paper II). Forty-two resuscitations 
were performed by midwives (21 in LMA group and 21 in FM group), whereas the 
remaining 7 (14%) were carried out by physicians (4 in LMA group and 3 in FM 
group). All newborn infants were born after an emergency caesarean section. 
Supervisor assistance was required in 13% of resuscitations with LMA and 24% of 
resuscitations with FM. Conversion to the other device because of poor response was 
done in 0% of the LMA group and 44% in the FMV group. No adverse events, such 
as bleeding, laryngospasm or vomiting, were reported in either group. There was no 
difference in outcome at 48 h between the groups. Thirteen patients were admitted to 
the neonatal unit (5 in LMA arm and 8 in FM arm), one patient died and 2 patients 
had moderately/severe hypoxic ischemic encephalopathy in the FM arm. 
In paper III, resuscitations were performed by midwives without direct supervision. 
Forty-six infants (23 in the LMA group and 23 in the FM group) were included in the 
study. Conversion to an alternative airway was done in 4% of the LMA group and 
26% of the FMV group. No side-effects reported in the FMV group, but there were 
4% (1 case of mouth bleeding, with good clinical outcome) in the LMA group. 
Outcome data at 7 days will be published in the main study (Annex I). 
4.3 Effect of LMA on resuscitation time compared to FMV 
In paper II, PPV started after a mean of 64s (60s in LMA arm and 68s in FM arm; 
p=0.26). Mean time to spontaneous breathing was 153s (SD 59) with LMA and 216 s 
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(SD 92) with FM (p=0.005), a mean reduction of 31% (95% CI 11% to 44%). Total 
ventilation time was also shorter in the LMA group than in the FM group (mean 93s 
vs 140 s, p=0.02; Table 4). 
In paper III, ventilation started at a median 39 seconds after birth (IQR 25-68) and 
lasted a median of 95 seconds (IQR 63-180) in the LMA group and 197 seconds (58-














Start of PPV (s) a  60 (11)  68 (36)  0.26   0.88 (0.70 to 1.10) b 




3 (13)   6 (24)   0.46   0.46 (0.07 to 2.52) d 
Conversion to 
alternative device c 




4.4 Respiratory function during resuscitation of asphyxiated newborn infants 
with LMA  
In paper III, the respiratory function was analyzed during the first 60 breaths to avoid 
contamination between arms. Mean mask leak was 46% (SD 24) in the FM arm and 
39% (SD 20) in the LMA arm (p=0.32). Peak inspiratory pressure (PIP) was 34.5 cm 
H2O (SD 8.2) in FM and 39.4 cm H2O (SD 7.6) in LMA (p=0.04). Mean expiratory 
tidal volume was 8.8 ml/kg (SD 5.8) in FM arm and 8.2 ml/kg (SD 3.4) in LMA arm 
(p=0.66), whereas mean inspiratory tidal volume was 16.2 ml/kg (SD 8.0) in FM 










Time to start ventilation (s) a  36 (27‐73)  45 (25‐62)  0.99 
Ventilation time (s) a  95 (63‐180)  197 (58‐662)  0.22 








4.5 Heart rate response during resuscitation with LMA and FMV 
In paper II, HR increased during the first 240s after birth (p<0.0001) and was higher 
in the LMA arm than in the FM arm (p=0.0006). The rate of increase was similar in 
the 2 arms (p=0.48). The proportion of patients with HR <100 bpm decreased in both 
arms from ~80% at 30s after birth to 4% at 240s. 
In paper III, HR rate was higher in the LMA than the FM arm (p=0.05) and increased 
during the first 60 breaths (p<0.0001), but the difference between the LMA and FM 
arms reduced with time (p=0.04). In 26 infants with HR<100 bpm at start of 
ventilation, a shorter time was needed to achieve HR>100 bpm in LMA (median 13 
seconds, IQR 9-15) in comparison to the FM arm (median 61, IQR 33-140; 
p=0.0002). 
4.6 Needs for alternative airway 
In paper II, all procedures were effective in the LMA arm, whereas 11 participants 
receiving FM were switched to LMA after 150 s because response to FMV was 
deemed unsatisfactory by the supervisor due to poor HR response and/or lack of chest 
rise (p=0.0002). 
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In paper III, 3 infants in the FM arm and none in the LMA arm were converted to the 
alternative device due to the continued unsatisfactory response after 3 min of 
resuscitation (p=0.23). Advanced resuscitation was needed in 3 infants in each arm 
(p=0.99). Intubation was needed in one LMA infant and 3 FM infants (p=0.60). 
4.7 The importance of airway obstructions 
Routine suctioning of the airways was performed on 56.6% of the FMV group and in 
52.2% of the LMA group in the 46 participants in paper III. Median suction duration 
was 30 seconds (IQR 23-42) in the LMA arm and 29 seconds (IQR 11-41) in the 
FMV arm (p=0.62). Complete or partial obstruction of the airways with poor chest 
movements, expiratory tidal volumes <4 ml/kg and/or persistent bradycardia was 










Response to corrective measures (mask reposition, oral suction and increased 
ventilation pressure) failed for 26.1% in the FMV group and 17.4 % in the LMA 
group (table 6). Deep oral and/or tracheal suctioning using laryngoscope with a 
modified Laerdal Penguin (figure 16) improved heart rate and expired tidal volumes 
in all treated participants. These observations were not part of the original paper. 
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5. Discussion 
The studies in this thesis provide valuable data on a number of points that will be 
discussed in the following order:  
a) a manikin-based training model for implementation of neonatal resuscitation 
with LMA,  
b) safety of task-shifting the use of LMA to midwives performing newborn 
resuscitation,  
c) the effect of LMA compared to FM on total resuscitation time and heart rate 
response,  
d) effect of LMA compared to FM on leak and tidal volume delivery, 
e) the rate of apparent failed ventilation due to leak or airway obstruction and 
necessitating alternative airways.  
All the interventions evaluated could be implemented in low-resource settings where 
most deaths and disability from birth asphyxia occur. 
5.1 Teaching ventilation with LMA in a manikin model 
In the preclinical manikin study, we found that the use of LMA could be taught easily 
to healthcare workers in low-resource setting within the framework of the HBB 
curriculum. The PPV performance was better with the LMA and the participants 
found the LMA much easier to use. 
Training models for the use of LMA in newborn have not been extensively 
investigated. In adult bedside training models, LMA insertion could be taught to 
unskilled personnel and achieve the same high level of success (94%) as skilled 
personnel (98%).118 Brief manikin-only training (<15 min) in high-resource settings 
have reached 100% insertion success in neonatal models119 120, and our data are in 
agreement with these findings. The participants completed an LMA training module 
(<15 min), and could all establish PPV on the first attempt. In contrast, 7/25 
participants (18%) failed to establish PPV with FMV within 30 seconds. It is 
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noteworthy that all participants were experienced FM users and had received repeated 
HBB and/or Newborn Life Support (NLS) training. This could imply that high-dose 
refresher training for LMA insertion skills might not be as critical as for FMV, but 
resuscitation involves not only the insertion technique. Future studies will be needed 
to address this aspect before implementation of LMA as an interface for newborn 
resuscitation. 
Heath staff unfamiliar with LMA may prefer FMV in the delivery room, but this may 
change after training. In their LMA manikin trial, Gandini et al. (2004) found the 
preferred technique for neonatal resuscitation reversed from 6% to 80% after a 
training session. Zanardo et al. also found higher approval rate for LMA resuscitation 
compared to FMV after manikin-training in a low-resource setting.121 Our study also 
reported a higher effectiveness score (ease of application/ventilation) for the LMA 
perceived by the participants delivering PPV in the manikin.  
The i-gel LMA was chosen for this study. It is the only device on the market with a 
solid gel cushion replacing the inflatable cuff. The advantage of this design is ease of 
use. The extra equipment and time necessary for manual cuff inflation in alternative 
devices may delay the start of PPV, but this aspect needs to be investigated. A recent 
manikin study compared 7 different neonatal LMAs available on the market. The i-
gel LMA was rated as easy to insert by 100% of the participants. The corresponding 
rates for the 6 other devices ranged from 40 to 95%.32  
This study has some of the limitations expected from manikin studies in regard to 
translation of skills acquired during simulation-based training into clinical practice. 
The study was conducted at the labor ward theatre and the number of participants was 
limited to 25, so the results could not be stratified according to work categories. On-
the-job training was conducted for practical reasons and pre- and post-training 
knowledge assessment was not performed. Despite these limitations, an evaluation of 
PPV performance of midwives with LMA on the manikin was crucial before bringing 
this new resuscitation tool into clinical practice. 
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5.2 Safety and task-shifting 
The trials (paper II and III) demonstrated for the first time that midwives could safely 
perform newborn resuscitation with LMA. We used high-definition video recordings 
to collect resuscitation data that included any interventions from supervisor, switch to 
alternative device after failed PPV, and monitoring indicated adverse events. The 
cameras in paper II were manually operated; however, this minor disturbance did not 
interfere with clinical activity. The video monitors in paper III were automated. The 
staff and research assistants participated in weekly meeting when difficult cases were 
discussed. The trial team gave constructive feed-back in cases when detrimental 
practices were observed, such as excessive stimulation or prolonged suctioning of the 
airways. These issues will be discussed as potential bias in chapter 5.7.7. 
The LMA was introduced in clinical practice >30 years ago and has become an 
indispensable airway management tool in the hands of anesthesiologists. Task-
shifting the use of an LMA device to non-doctor or inexperienced health staff in 
resource-limited settings could be a way of improving the outcome of newborn 
resuscitation. In Mozambique, 90% of the caesarean sections at the district hospital 
level are performed by non-doctors without a significant difference in outcome 
compared to medical doctors.122 There is a lack of high-quality evidence assessing 
whether the skills acquired from LMA insertion on the manikin translates into clinical 
practice. Two experienced study doctors supervised newborn resuscitations in the 
first task-shifting trial involving midwives using LMA (paper II). Bedside 
supervision included practical advice, corrective measures to improve ventilation and 
hands-on assistance where required. Interventions were required in 13% of 
resuscitations with LMA and 24% of resuscitations with FM. Switch to the 
alternative device was advised after 180s in case of poor chest rise and/or heart rate 
response, despite corrective measures. 
Nearly half (44%) of the neonates did not respond well to FMV within the first 2 min 
of ventilation. Shifting to LMA resulted in successful resuscitation. No participant in 
the LMA group had to be converted to FMV.  
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In paper III, resuscitations were performed by midwives without direct supervision. 
Conversion to an alternative airway was less frequent, and occurred in 4% of the 
LMA group and 26% of the FMV group. We opted to offer all participants in the trial 
the best possible resuscitation practices available for low-resource settings. The staff 
had received a full-day training course focused on airway management. Detrimental 
suction practices observed in the previous study were discussed and discouraged. 
Research assistants prepared and sterilized the resuscitation equipment after each use.  
Drake-Brokeman et al. published in the Lancet (2017) adverse event data from a large 
RCT that compared the use of LMA vs. endotracheal tubes in pediatric anesthesia.84 
Patients managed with endotracheal tubes were nearly 5 time more likely to have 
adverse events (19%) compared to LMA (4%). This has been announced as a 
paradigm shift, should the results be confirmed.84 Both our studies also reported a 
very low rate of adverse events. In paper II, no adverse events such as bleeding, 
laryngospasm or vomiting were reported in either group. In paper III, no adverse 
events were reported in the FMV group and 4% in the LMA group (1 case of mouth 
bleeding with good clinical outcome). The LMA appears to be safe even in the hands 
of non-doctor staff. The level of bedside supervision after manikin training needs to 
be clarified. Data from the NeoSupra trial will help us understand if LMA 
resuscitation can be implemented safely without formal clinical supervision. 
5.3 Ventilation time 
Based on our papers II and III, the LMA may be more effective than FMV in terms of 
shorter ventilation times; time to spontaneous breathing and total ventilation time 
were consistently shorter in the LMA arm compared to the FM arm. Researchers 
commonly use stopwatches to register ventilation time during resuscitations but the 
stressful situation increases the risk for mistakes. Instead, we assessed the ventilation 
time by video review with 2 separate observers (paper II and III) and RFM (paper 
III). Non-matching data was reviewed a third time. Ventilation time was shorter in 
the LMA groups, 93 s (paper II) and 95 s (paper III), compared to the FM group, 140 
s (paper II) and 193 s (paper III). The interquartile range (IQR) in the FMV group 
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(paper III) was very large (58-662) and the small sample size presents obvious 
limitations. The results, however, are in line with previous studies, including a 
Cochrane review in 2018, that showed that PPV was more effective with LMA 
compared to FMV (paper II).123 Resuscitations in previous studies were all performed 
by doctors using traditional LMAs with an inflatable cuff.121 124-128 Our results suggest 
that even in low-income settings, non-doctor staff can improve aeration of the lungs 
using uncuffed LMAs and potentially shorten the hypoxic process. Ersdal et al. in a 
study from Tanzania reported that 30 s delay in initiation of PPV increased mortality 
and morbidity by 16%.37 Reduction in ventilation time could have a similar impact. 
This aspect will be investigated in the NeoSupra trial (Annex I). PPV is interrupted 
for > 30% of the total ventilation time, even in high-resource settings.129 Shorter 
ventilation time could be the result of fewer interruptions during LMA ventilation 
since the mask does not need to be repositioned and the fact that the operator actually 
needs to actively hold the bag for as long as it is connected to the LMA. Another 
important aspect is that PPV with LMA can be delivered with just one hand. This 
allows the caretaker to reposition or transport the baby without interrupting PPV. 
which may be crucial in understaffed setting were midwives may need to resuscitate 
the baby beside the mother.  
5.4 Heart rate response  
The LMA also provided a faster HR recovery during resuscitation in our clinical 
trials (paper II and III). A rapid increase of HR in the asphyxiated babies is 
considered the best indicator of adequate ventilation.74 130 131 A HR <100 is one of the 
thresholds for starting PPV. The HR will rise rapidly in particular if an infant is in 
primary apnea and/or receives efficient PPV. Severely compromised infants with 
secondary apnea and/or suboptimal ventilation will experience a more gradual rise of 
HR. In the first clinical study (paper II), HR increased faster in the LMA group 
during the first 240 s after birth. HR data was collected with the NeoTap LS for 
practical reasons, but the method had not been validated at the time of the trial. 
Another limitation is that HR was not collected at the start of PPV, but at fixed 30 s 
intervals after birth. HR registration was improved in the subsequent study (paper III) 
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with additional ECG data collected from beginning to end of PPV. We recorded HR 
data continuously and registered changes of 5 bpm or more. Twenty-six infants had a 
HR<100 at start of ventilation. The data showed a similar faster increase in HR in the 
LMA group. The time to achieve a HR >100 was dramatically shorter in the LMA 
group median, 13 s compared to the FMV group with a median of 61 s (p=0.0002). It 
is unclear if the improved HR response is the result of more efficient PPV from the 
LMA, less interruptions of PPV during LMA ventilation, or other factors such as 
sympathetic stimulation from the LMA insertion. Results may also have been 
influenced by a shorter time to start ventilation in the LMA group in paper III 
(p=0.99).  
Increased heart rate response has been linked to higher delivered Vte.114 132 Tactile 
stimulation of the oropharynx region can also elicit a sympathoexcitative response in 
the human.133 Anecdotal observations from the video review reveal that some infants 
react with a HR increase at the moment of LMA insertion before initiation of PPV. 
On the other hand, application of the face-mask could have activated the trigeminal 
nerve, known to induce bradycardia and inhibit breathing134 135 Autonomous HR 
response during PPV with various interface requires further investigations.  
5.5 Mask leak and tidal volumes 
The LMA used in resuscitation provided similar mask leak and Vte compared to 
FMV (paper III). To our knowledge, this is the first clinical report evaluating 
respiratory function during newborn resuscitation with LMA. Tracy et al. (2018) 
recently published a manikin trial that compared the i-gel uncuffed LMA with face-
mask and 6 other LMA designs. Mean mask leak in the i-gel was only 4%, whereas 
the leak from other devices ranged from 35-44% for the FM and 46-65% for the 
different LMA designs.136 In our clinical study, the mean mask leak with i-gel was 
39%. Mask leak from the FM, on the other hand was 46%, similar to the manikin data 
and a recent clinical trial from Tanzania.114 The large difference in LMA leak 
between manikin and clinical data was unexpected, but results from simulated models 
can be misleading. Accurate anatomical details are just one of the many parameters. 
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Tissue moisture, airway compliance, fluid in the alveoli, and natural resistance from 
cartilage and bony structures also need correct modeling if high-fidelity manikins are 
to be improved. The causes of leak in FMV are well understood and include mask 
leak at the rim, head positioning, laryngeal adduction, blockage of nose and mouth 
from excessive pressure and pharyngeal obstruction by the tongue.137 Causes for 
LMA leak are not as well investigated. Oropharyngeal leak (or seal) pressure is an 
essential characteristic of LMA as it determines the pressure threshold when the 
LMA starts leaking at the interface. The mean oropharyngeal leak pressure reported 
for the i-gel in pediatric anesthesia ranges between 20 and 27 cm H2O and compares 
favorably to other devices.138 The mean PIP delivered by the self-inflating bag during 
LMA ventilation was 39.4 cm H2O. The high mean pressure could be caused by users 
blocking the pressure-release valve or forcefully compressing the bag. Leakage at this 
pressure level might be useful if caused by excessive PIP and could protect the 
infant’s lung from barotrauma caused by high Vte.139 However, excessive mask leak 
(>60%) occurred in 17.4% in the LMA group and 30.4% of the FM group and was 
associated with low Vte (<5 ml/kg). Oropharyngeal leakage and gastric insufflation in 
LMA has been described in pediatric anesthesia and can be the result of a 
misplacement of the LMA, with the tip of the device inserted into the entrance of the 
esophagus.140 We also observed occasional cases were the LMA was unintentionally 
rotated or twisted from the vertical axis. The staff practiced corrective measures that 
included a slight retraction of the LMA in the case of absent chest movements and/or 
gastric distention during the training. Additional review of the video data could help 
us determine if these actions were translated into clinical practice. 
Mean Vte was 8.8 ml/kg in the FMV group, 0.6 ml/kg more than the LMA group 
(p=0.66) despite a smaller leak (p=0.32) in the LMA compared to FM. Van Vonderen 
et al. also reported lower Vte in preterms receiving PPV with ETT compared to FMV 
and speculates that FMV pressurizes the highly compliant oropharyngeal region.141 
Mask distention may also contribute to Vte in FMV.142 O’Donnell et al. calculated in 
a manikin model that up to 18% of Vt could be distending the mask.113 Tidal volumes 
above 10 ml/kg where also more common in infants ventilated with FM. We 
observed abdominal movements after video reviews in 3/23 infants in the FMV 
62 
group. These 3 infants had abnormally high Vte (range 17-21 ml/kg) suggesting that 
air entering and exiting the esophagus and stomach could contribute Vte, adding to 
the dead space. We speculate that this phenomenon could be clinically relevant, 
particularly in infants with airway obstruction or low lung compliance. Ventilation 
with LMA provides the same direct access to the lower airways as in ventilation with 
an ETT and could establish functional residual capacity (FRC) earlier despite lower 
Vte.  
5.6 Too much too soon or too little too late: the importance of managing 
airway obstructions 
Routine airway suctioning may be harmful and was recently de-emphasized in in the 
second edition of HBB.11 In 2016, our collaborator, Dr. C. Lubulwa reviewed 99 
video-recorded resuscitations performed at Mulago National Referral Hospital in 
Kampala.143 Routine suctioning was performed in 81% of infants prior to 
resuscitation. Detrimental suction practice affecting the start of ventilation was 
common, with only 13% of cases deemed appropriate. The median start time to 
ventilation in the delivery room was 163 s (IQR 141-202). 
During training, the trial team highlighted critical aspects of the current guidelines, 
such as avoiding prolonged suction and emphasizing the HBB concept of the Golden 
Minute (i.e. start ventilation of the non-breathing baby within 60 seconds). Secondary 
data analysis from the respiratory function monitor and associated videos (paper III 
and unpublished data) show that routine suctioning was reduced to 56.6 % in the 
FMV group (table 5). We also found that complete or partial obstruction of the 
airways during resuscitation occurred in about a quarter of all cases, necessitating 
aggressive suctioning to remove mucous plugs from the airways. This puzzling 
finding seems unrelated to the meconium aspiration syndrome since infants recovered 
from the respiratory distress after removal of the plug. The focus of suction research 
has mainly been mainly on preemptive clearing of the airways.144-147 NRPs seventh 
edition has suggested against routine suctioning, even of depressed infants to 
minimalize delay in ventilation. Chiruvolu et al. have monitored admissions to the 
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NICU prospectively after implementation of the guideline changes and noted a 
significant increase of admissions to the NICU for respiratory failure.148 To our 
knowledge, the specific problem of airway obstruction during PPV has not been 
investigated. Removal of the mucous plugs with standard bulb syringes was 




However, deep suctioning of the trachea was necessary in 3/46 cases. Active suction 
systems are rarely available outside high-resource settings. An adaptation of the 
Laerdal Penguin, paired with a 3.0 standard ETT tube and digital (=finger) intubation, 
proved useful in those cases (Figure 17). Resuscitation with LMA did not always 
seem to solve this clinical problem. In the LMA group (paper III), 17.4 % of infants 





Airway plugs were not always removed, despite the suspicion of obstruction. Animal 
studies have suggested that glottic and hypoglottic adduction may also play a critical 
role in particular for PPV of the preterm <32 weeks in particular.149 It remains unclear 
if this fetal physiological mechanism, involved in enhancing lung expansion and lung 
growth, plays a critical role during resuscitation, and if LMA could minimize this 
type of airway obstruction.  
We know that a routine suction practice may delay the onset of ventilation. However, 
our clinical observation suggests that compromised ventilation due to critical airway 
obstruction during newborn resuscitation may be more common than previously 
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thought, at least in this population with its high proportion of depressed infants. A 
high frequency of obstetric delays, maternal dehydration and chorioamnionitis in our 
research setting are possible causes of this serious complication. Deep suctioning 
methods are easy to learn and do not require special equipment. Although neonatal 
suction-practice has been an area of controversy for years, it may be worthwhile to 
assess its prevalence and exploring further the causes of postnatal airway obstruction 
in low-resource settings. 
5.7 Methodological considerations and biases 
5.7.1 The manikin study  
Only a limited number of pediatric LMA studies had been conducted prior to our 
trials.120 121 The design of the manikin study (paper I) had certain limitations. First, 
the number of participants was limited. We conducted the pilot trial in the labor ward 
theatre and trained only the staff attached to this unit. Preclinical manikin studies can 
be regarded as equivalent to phase 1 in-vitro studies in pharmacological trials. The 
participants found insertion maneuvers for the LMA very easy, yet the model could 
never offer the size and anatomical variations or the wide size range from term to 
preterm infants. Health workers in the labor units had no previous experience of 
LMA. It would have been unethical to set up a clinical trial directly without 
knowledge of performance on a manikin and acceptability of the device. Despite 
obvious limitations, the findings served as a useful stepping-stone as we planned the 
clinical trials. 
5.7.2 The clinical trials 
Randomized controlled trials (RCTs) are designed to evaluate the causal relationships 
of a medical treatment strategy. A well-designed randomization method is paramount 
in establishing causation and to minimize any bias. Blinding was not possible as in 
most non-drug trials. Thus, bias from potential differential care of respective study 
arm could not be eliminated. An unmasked trial, however, offers the advantage of 
safety and effectiveness analysis in a real-world situation. We performed intention to 
treat (ITT) analyses in paper II and III. An option to switch to the alternative device 
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in the case of PPV failure after 3 min was part of the study design for ethical reasons. 
This short “wash-out” period with the intended device, challenged a true 
measurement of the effect of treatment. A per protocol (PP) analysis is likely to have 
biased the results, since the most depressed children may have shifted to the other 
arm in a differential manner.  
We considered the calculation of the sample size for this task-shifting trial (paper II) 
appropriate, since it emphasized the safety aspects. The calculation for paper III was 
based on evidence-based assumptions from our own anecdotal observations and 
available manikin data. In hindsight, the small sample proved to be a problem in both 
studies. Important secondary outcomes, such has heart response and ventilation time 
(paper III) were not statistically significant. The wide confidence intervals could have 
generated Type I errors. The design of the NeoSupra trial is based on the pragmatic 
assumption that only a large reduction of adverse outcomes (25%) would justify the 
implementation of a radically different and more expensive resuscitation method. 
Setting up prospective randomized controlled trials in resource constrained settings 
presents particular methodological challenges. We used Cochrane Collaboration 
assessment tools (table 7) to help us identify design flaws and possible biases in the 
preparation of the trial protocol (paper III, annex).150 The tool for assessing the risk of 
bias in randomized trials covers 6 domains of bias: performance bias, detection bias, 
attrition bias, selection bias, reporting bias, and other bias. 
Table 7. Risk of bias in paper II‐III and Annex (NeoSupra trial) 
 Paper II Paper III Annex 
Random sequence generation  Low risk  High risk  Low risk 
Allocation concealment  Low risk  Low risk  Low risk 
Blinding  High risk  High risk  High risk 
Incomplete outcome data  Low risk  High risk  High risk 
Selective reporting  High risk  High risk  Low risk 
Other bias  High risk  High risk  ? 
 
5.7.3 Performance bias 
Performance bias may occur due to the study team’s awareness of the allocation of 
the participant. Health workers in the delivery room where not masked to the 
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intervention. The belief that the LMA was a life-saving device, could have led to 
some unwarranted switches in device. However, the use of LMA in the case of PPV 
failure with FM would have been likely in real clinical situations, limiting the impact 
of this bias in the primary outcome analysis. 
5.7.4 Detection bias 
A systematic difference in how outcomes are determined between study arms is 
referred to as detection bias. In paper III, we have reasons to believe that tidal volume 
calculated from the respiratory function monitor may have overestimated the Vte in 
the FMV group (Chapter 5.5).  
5.7.5 Attrition bias 
Attrition bias is the uneven loss of participants between study arms, but it seems not 
to have affected our trials. The primary outcomes of paper II and III were collected at 
the time of intervention. In the NeoSupra trial, significant efforts were made to keep 
the loss to follow-up < 5% 
5.7.6 Selection bias 
Selection bias is caused by improper randomization and introduces a systematic 
difference between study arms or populations. This type of bias is difficult to measure 
and adjust for. The limitation of the chosen randomization processes has been 
previously discussed. In paper III, participants were only recruited when a study-
doctor was on duty, increasing the risk of a selection bias. The external validity of the 
trial may also be challenged, since the population in this large referral hospital is 
probably going to be more severely affected than in a lower health care center. Only a 
large multi-center trial could mitigate this effect. In the case of severely ill mothers 
suffering from conditions such as eclampsia, sepsis or uterine rupture developing, the 
oral consent requirement could lead to a selection of a less critically-ill cohort.  
5.7.7 Reporting bias 
Reporting bias occurs when selected outcomes from clinical trials are chosen for 
publication. Selective reporting was mitigated by prior publication of the outcomes 
(paper II-III) in clinicaltrials.gov. In paper III, we also chose to report rescue 
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suctioning outcomes because of the high occurrence of airway obstruction, which had 
not been predicted in the design of the trial. 
5.7.8 Information bias 
Improper data collection techniques can lead to information bias. The team 
maximized efforts to assure the quality of the data collection. Video review could 
complete missing data from research assistants in timing the resuscitation 
intervention. We performed dry runs of the data collection before recruitment started 
to improve the methodology of data collection. In paper III and in the NeoSupra trial, 
data managers used double data input. We performed an extensive data cleaning 
process before data analysis in paper III because of artefacts generating implausible 
data in ~10% of the recorded breaths. 
The RAs assessed subjectively the Apgar score. The scoring can be altered by several 
factors during resuscitation and reliability has not been studied.66 Stopwatches were 
used to record time from delivery to table, but double control from the RA 
supervisors showed that this data was often unreliable, a particular parameter that 
could not be corrected by video review. 
5.7.9 Other biases 
The Hawthorn effect is controversial and said to occur when participants or 
researchers modify their behavior by their awareness of being observed.151 Interaction 
between the midwives and the asphyxiated infants was monitored by video and 
research assistants. Feedback was given to the staff for ethical reasons where serious 
deviations from guidelines were observed. The impact of the Hawthorn effect and 
internal validity of the studies could have been estimated using qualitative methods. 
A separate qualitative study with interviews of the focus group discussing the 
midwife’s perception of their work and training is underway, which could help us 
understand behavioral aspects. An informal review of historical outcome data from 
the hospital ledgers seems to imply a positive impact on mortality rates that could be 
affecting both study arms. 
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5.7.10 A trial effect? 
We cannot exclude that a “trial effect” was inadvertently introduced that would be 
systematically beneficial for all participants during implementation of the trials. 
Guidelines were more likely to be followed, new equipment was introduced in the 
delivery room, careful recycling of the resuscitation devices improved hygiene, and 
clinical feedback was given to the health workers. Participation in a trial is likely to 
be advantageous regardless of the study arm, but the evidence from the review of 17 
RCTs was inconclusive.152 We cannot exclude the unintended introduction of the trial 
effect that could affect the external validity of the results. 
5.8 Emergency research ethics in vulnerable populations 
The work presented in this thesis is the result of a collaborative of a partnership 
involving the host country. It seemed most relevant to conduct the trials in one of the 
country’s large national referral hospitals because of the high number of participants 
required in the trial and the relatively low proportion of infants affected by birth 
asphyxia. The Ethics of Research Related to Healthcare in Developing Countries 
report from the Nuffield Council on Bioethics presents an ethical framework based on 
“4 sound principles of duty – the duty to alleviate suffering, to show respect for 
human beings, to be sensitive to cultural differences, and not to exploit the 
vulnerable.153 The problem of informed consent in an emergency involving a care-
taker in labor is particularly challenging.154 The Declaration of Helsinki mentions a 
possibility of using deferred consent in a potentially life-threatening situation, when 
time constraints do not allow ordinary prospective consent; such trials remain 
controversial.155 Unifying guidelines for emergency medicine research are still 
missing, but a review of the current literature offered a basis for discussion with the 
MREC preparing for the trials.154-163 Extensive discussions with clinical experts and 
members of the ethical board were necessary to find a way of obtaining consent 
without delaying intervention. Deferred consent was approved for the first pilot trial 
(paper II), since an experienced anesthetist or neonatologist would supervise all 
interventions. A 2-tiered procedure for consent was implemented for the NeoSupra 
trial, including paper III, because of the size of the trial and the risks involved in 
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unsupervised resuscitation. This model had been applied in a similar trial in the 
hospital.117 Free medical care was not a motivation for participation, but caretakers 
received a small travel compensation for follow-up visits. We faced unexpected 
difficulties when caretakers had to be approached in cases of a very early neonatal 
death. Research assistants were initially reluctant to increase the distress of caretakers 
with the deferred consent information. The inclusion of these cases in the NeoSupra 
trial (Annex) was crucial, since mortality was a primary endpoint. A deferred consent 
process with proper supervision from the trial team was successfully implemented 
after feedback from the research assistants. Caretakers in this situation are 
particularly vulnerable, and there are reasons to believe that waiver of consent could 
have been more appropriate. The 2-tiered process was labor-intensive and involved 
the presence of a dedicated research assistant 24/7. There are concerns that this cost-
prohibitive method could potentially delay critical clinical investigations. Indeed, 
emergency medicine trials have become less frequent with current legislations 
creating barriers for potentially life-saving studies.164 165 A solution to this situation 
would be to involve community leaders and stakeholders in the design of ethical 
design of high-risk trials. Such a method could provide a deeper understanding of 
local cultural contexts, and ultimately benefit both the participants and the trial.166 A 
detailed discussion of this approach is beyond the purview of this thesis. Our studies, 
however, imply that much effort is still needed to improve current guidelines for 
ethically challenging neonatal resuscitation research. 
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6. Conclusions 
 The LMA was more effective in establishing PPV in the manikin and user 
satisfaction was higher. 
 LMA was more effective than FM in reducing time to spontaneous breathing.  
 LMA was associated with faster HR recovery compared to FM in newborns 
with bradycardia.  
 Mask leak and tidal volume in LMA was similar to FMV 




7. Implications and future perspectives 
7.1 Implications for policy 
The time has come to take further steps that will enhance newborn resuscitation 
globally. According to the current guidelines, LMAs should be used as an alternative 
airway if ETT is unavailable or unsuccessful. FMV, even under optimal conditions, 
will never solve the problem afflicting hundreds of thousands of asphyxiated infants 
in need of advanced airway management. Non-doctor staff, in particular in large 
referral facilities, needs to be trained to master enhanced resuscitation skills, 
including LMA ventilation. Current evidence and existing guidelines should prompt 
the WHO to consider adding the LMA to the list of priority medical devices for 
essential reproductive, maternal, newborn and child health. Stakeholders and 
ministries of health will also need cost-analysis data as they target large-scale 
implementation. Single-use and reusable LMAs remain at this time cost-prohibitive 
in resource-limited contexts. The LMA used in this study retails at ~12 $. Our data 
could contribute to the development of a low-cost reusable LMA for the global 
market. Preterm infants are notoriously challenging to ventilate with face-mask, and 
dedicated LMAs for infants of <1500g are warranted. A standardized curriculum that 
includes a low-cost manikin would be useful when implementing LMAs at secondary 
and tertiary levels.  
7.2 Implications for future research 
The combination of dry-electrode ECG, respiratory function monitor and HD video 
seems to be a winning combination in this type of investigation. We need to 
understand how different LMA designs may impact the resuscitation performance on 
preterm and term infants. Different manikin designs also need to be evaluated. The 
need for aggressive suctioning after failed PPV due to tracheal obstruction requires 
further investigation. Cross-sectional prevalence studies in various settings, combined 
with the analysis of the viscoelastic and microbiological properties of the tracheal 
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plugs would be of great importance for our understanding the pathophysiological 
mechanisms of this under-reported condition. 
Finally, will the superior ventilation performance of the LMA also decrease neonatal 
mortality and neurological disability? Real progress has to be made if we are to reach 
the Sustainable Development Goal number 3 (SDG-3) of a global neonatal mortality 
rate of <12 in 1,000 live births by 2030. We have completed the NeoSupra trial in 
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ABSTRACT
Aim: We compared the performance of personnel in a low-resource setting when they
used the I-gel cuffless neonatal laryngeal mask or a face mask on a neonatal airway
management manikin.
Methods: At Mulago Hospital, Uganda, 25 doctors, nurses and midwives involved in
neonatal resuscitation were given brief training with the I-gel and face mask. Then, every
participant was observed positioning both devices on three consecutive occasions. The
success rate and insertion times leading to effective positive pressure ventilation (PPV)
were recorded. Participants rated the perceived efficiency of the devices using a five-point
Likert scale.
Results: The I-gel achieved a 100% success rate on all three occasions, but the face mask
was significantly less effective in achieving effective PPV and the failure rates at the first,
second and third attempts were 28%, 8% and 20%, respectively. The perceived efficiency
of the devices was significantly superior for the I-gel (4.7  0.4) than the face mask
(3.3  0.8).
Conclusion: The I-gel was more effective than the face mask in establishing PPV in the
manikin, and user satisfaction was higher. These encouraging manikin data could be a
stepping stone for clinical research on the use of the I-gel for neonatal resuscitation in low-
resource settings.
INTRODUCTION
Annually, 136 million babies are born worldwide. Approx-
imately one million die each year due to intrapartum-
related events, 96% of them in low- and middle-income
countries (1–3). Successful resuscitation could prevent a
large proportion of these deaths and improve the outcomes
of neonates surviving asphyxia (3,4). Therefore, all birth
attendants, including physicians, midwives and nurses,
should have the knowledge and skills required to perform
neonatal resuscitation (5). Providing effective positive
pressure ventilation (PPV) is the single most important
component of successful neonatal resuscitation (5). Venti-
lation is routinely initiated with face mask ventilation
(FMV) followed by endotracheal intubation (ETT) in cases
of FMV failure or the need for prolonged ventilatory
support. Both these techniques may be difficult to perform,
resulting in failure of effective resuscitation. Important air
leakages and airway blockage have been reported during
FMV. Skilled staff are required when ETT is performed (5).
The laryngeal mask airway (LMA) may be considered
during resuscitation as an alternative to FMV or ETT for
PPV in newborns weighing more than 2000 g or delivered
around, or after, 34 weeks of gestation (5). Several publi-
cations including a Cochrane review have shown that LMA
achieved effective PPV in most of the treated patients, with
Abbreviations
ETT, Endotracheal tube; FMV, Face mask ventilation; LMA,
Laryngeal mask airway; PPV, Positive pressure ventilation.
Key notes
 This study compared the use of the I-gel cuffless
neonatal laryngeal mask or a face mask on a neonatal
airway management manikin in a low-resource setting.
 The I-gel was more effective in establishing positive
pressure ventilation, and user satisfaction was higher
among the 25 doctors, nurses and midwives who took
part.
 These positive findings could encourage further clinical
research on the use of this device in low-resource
settings.
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a range of 95–99% (6–9) and reduced the need for ETT
(1,10). In all of the previous studies, a classic inflatable size
1 LMA was used. The I-gel (Intersurgical Ltd, Wokingham,
Berkshire, UK) is a new model of supraglottic airway device
that has been made available and is designed to provide an
efficient seal to the larynx without an inflatable cuff. The
risk for trauma is minimised (2), and insertion is easy with a
low risk of tissue compression or dislodgement (11). All
these characteristics make the I-gel a potentially very useful
alternative to FMV and ETT, especially in settings where
the staff’s skills in performing PPV are low. No randomised
trials had been performed to evaluate the I-gel uncuffed
supraglottic airway device and compare it with the FMV for
neonatal resuscitation. A first step before conducting a
clinical study on the neonates was to evaluate a high-fidelity
training programme that could be implemented in health-
care facilities with limited resources in a low-resource
setting.
The aim of this study was to compare the performance,
namely the ease of insertion and time to establish effective
PPV, of personnel involved in neonatal resuscitation with
limited experience in airway management when using the
I-gel and face mask in a neonatal airway management
manikin. The effectiveness of the two devices, as perceived
by the participants, was also evaluated.
METHODS
A Helping Babies Breathe refresher course was held at
the Labour Ward Theatre, Department of Obstetrics and
Gynaecology, at the Mulago National Referral and Teach-
ing Hospital Kampala in December 2012. Two certified
neonatologists, who were also Neonatal Resuscitation
Program instructors (NP, DT), held the course, which
consisted of a didactic review of the Helping Babies Breathe
neonatal resuscitation flowchart and practical hands-on
skill stations. The lessons and practical skill stations
included topics on the first steps of neonatal resuscitation,
including thermal losses prevention, airway management
and stimulation, and the use of the face mask. An additional
module for training on the use of the I-gel was added.
The I-gel is a relatively new single-use supraglottic airway
device, and the size 1 device is designed for neonates
weighting 2–5 kg (Fig. 1). It comprises a soft, gel-like,
noninflatable cuff made of thermoplastic elastomer that fits
anatomically against the perilaryngeal structures and a rigid
bite-block that acts as a buccal stabiliser to reduce axial
rotation and malpositioning (11,12).
To teach the use of both devices, the face mask and the
I-gel, to health staff, we used a high-fidelity manikin model,
the SimNewB Laerdal (Laerdal, Stavanger, Norway). It
provides realistic airways and good feedback with chest rise
when effective PPV is provided. The face mask used was the
Laerdal neonatal resuscitator (Laerdal Medical, Stavanger,
Norway). We included all 25 of the staff available on
daytime duty on a particular week.
All participants had previously used the face mask on a
manikin model as well as in clinical practice for neonatal
resuscitation. However, all of them said it was the first time
they had placed a supraglottic airway device, in particular
an I-gel. After the course, participants were asked to
ventilate the manikin with the I-gel and face mask,
respectively. Each participant was then observed position-
ing and inserting each of the two devices on three
consecutive occasions. The order, starting with the I-gel
or face mask, was randomly assigned using closed envel-
opes. The success rate and time to establish full chest rise,
namely the insertion time, was recorded by a single
unblinded observer. If more than 30 seconds elapsed before
the chest rise was noticed, a new attempt was carried out. A
five-point Likert scale was used to evaluate the ease of
application and insertion and ventilation perceived by the
participants. The perceived effectiveness of respective
devices was scored by each participant immediately after
the performance: one for insufficient, two for sufficient,
three for fair, four for good and five for excellent. To avoid a
desirability bias, participants were only informed afterwards
of their involvement in this comparative study.
A convenience sample of healthcare volunteers was
studied, and no sample size calculation was performed.
The individual staff members consented to participate.
Data were collated and statistically analysed using the
statistical package STATISTICA, StatSoft version 6
(www.statsoft.com). Differences between the two devices
were determined using the paired t-test and the unpaired
t-test, respectively. A p value of <0.05 was considered
statistically significant.
RESULTS
A total of 25 healthcare providers, 12 doctors and 13
midwives and nurses, participated in the study. All 25
participants completed the study and obtained effective
PPV with the manikin model (Table 1). The I-gel enabled
them to reach effective PPV at the first attempt on all
three consecutive occasions. These performances were
Figure 1 The I-gel and the face mask used in the study.
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significantly better (p < 0.001) than those obtained with the
face mask. In fact, the face mask only allowed an effective
PPV on the first attempt in 18/25 (72%), 23/25 (92%) and
20/25 (80%) of the first, second and third occasions,
respectively. The mean and standard deviation insertion
times for the I-gel were not significantly different to the face
mask on the first (6.2  2.3 versus 8.3  4.7 seconds,
p = 0.18), second (5.2  1.1 versus 9.9  14.1 seconds,
p = 0.68) and third (4.5  1.0 versus 6.6  5.9 seconds,
p = 0.38) occasions. The effectiveness score expressed by
the participants for the I-gel on a five-point Likert scale was
4.7  0.4, compared with 3.3  0.8 for the face mask
(p < 0.001).
DISCUSSION
This manikin study was performed among birth attendants
in Uganda immediately after a training course of both face
mask and supraglottic airway device ventilation skills. The
25 participants obtained better PPV with the I-gel than the
face mask and found the I-gel much easier to use.
Our results demonstrate that both skilled and unskilled
participants could rapidly learn to ventilate the manikin
with the uncuffed supraglottic airway device. All partici-
pants achieved effective PPV on the manikin on all
attempts. Furthermore, PPV could be established more
rapidly, even if this difference was not statistically signifi-
cant. Several participants failed to establish PPV within
30 seconds with the face mask. These data confirm that it is
indeed a challenge to establish an effective seal with a face
mask and sustain good ventilation. It is important to note
that all participants had prior clinical experience with the
face mask, whereas it was the first time they inserted the
I-gel device.
Furthermore, the participants found it easier to establish
PPV with the I-gel compared to the face mask. The
acceptability and satisfaction expressed by healthcare
providers, especially in low-resource settings, is another
important issue to consider. Our data are in agreement with
a previous manikin study conducted in Kinshasa, Demo-
cratic Republic of Congo, where participants manifested a
high degree of approval of neonatal resuscitation using a
classic supraglottic airways device (13).
Both stillbirths and neonatal mortality are high in low-
income countries (2,3). As intrapartum-related complica-
tions, previously labelled as birth asphyxia, are responsible
for a large number of these deaths, programmes that aim to
improve neonatal management at birth are crucial (3).
Antenatal care improvements and an increase in the
proportion of births attended by skilled personnel are
mandatory to decrease intrapartum-related complications
(4,14). Bhutta and Black (3) have suggested that a strategy
based on low-cost training materials and standardised
training manuals and equipment such as manikins and
resuscitation bags may help to reach this goal. However, the
quality of educational interventions needs to be assessed in
simulated as well as clinical settings.
As effective PPV is the most important intervention
during neonatal resuscitation, educational efforts should
mainly concentrate on this task and it is essential that all
those involved in the care of newborn infants at birth are
able to perform this procedure (5).
The 2015 International Guidelines for Neonatal Resus-
citation state that a laryngeal mask may be considered
during resuscitation as an alternative to a face mask for PPV
among newborn infants weighing less than 2000 g or
delivered around or after 34 weeks of gestation (5). In the
setting of neonatal resuscitation, previous observational
studies have showed that LMA allowed effective PPV in
most of the patients that were treated, with a range of 95–
99% (6–8). One quasi-randomised study showed that the
LMA was more effective than face mask ventilation for
neonates with an Apgar score of 2–5 at one minute after
birth. The authors concluded that the LMA was safe,
effective and easy to implement for the resuscitation of
neonates with a gestational age of 34 or more weeks (10). A
further study, conducted in a middle-income country,
confirmed that the neonatal LMA Supreme (Teleflex Inc,
Wayne, PA, USA) was more effective than a face mask in
preventing endotracheal intubation in newborns with a
gestational age of 34 weeks or more and, or, an expected
birthweight of at least 1500 g needing PPV at birth (15). All
these studies were conducted using a cuffed supraglottic
airways device (6–10). The innovative design of the I-gel
could simplify insertion and should be well suited for this
task. A meta-analysis demonstrated that the LMA Supreme
and the I-gel supraglottic airways device models were
similarly successful and rapidly inserted during anaesthesia
in adult patients (16).
While our study demonstrated that the use of the I-gel
could be easily taught to local healthcare workers in low-
income countries, it does have some limitations. It was a
manikin study with only a small number of healthcare
workers involved. The training was carried out in situ at the
labour ward with limited time available. The knowledge
retention over time was not assessed, nor was the ability to
sustain PPV over a longer period of time. The skills acquired
Table 1 Insertion success rate, mean time to successful ventilation, perceived ease of
insertion and perceived effectiveness of ventilation with I-gelTM and FM
I-gelTM (N = 25) FM (N = 25) p value
Success rate n (%) n (%)
1st attempt 25 (100) 18 (72) <0.001
2nd attempt 25 (100) 23 (92) <0.001
3rd attempt 25 (100) 20 (80) <0.001
Mean time to
successful ventilation
Mean  SD Mean  SD
1st attempt (seconds) 6.2  2.3 8.3  4.7 0.18
2nd attempt (seconds) 5.2  1.1 9.9  14.1 0.68









4.7  0.4 (1–5) 3.3  0.8 (1–5) <0.001
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using the I-gel on the manikin have not yet been applied in
the delivery room. The insertion of the I-gel supraglottic
airways device may be more difficult in a neonate than in a
manikin. The comparison of the I-gel and face mask needs
to be reproduced in a clinical setting. If it turns out that I-gel
is superior to a face mask, the price issue must be addressed
for it to become a real alternative in low-resource settings. It
is a single-use device currently sold in the European Union
for the equivalent of 12 U.S. dollars.
CONCLUSION
The use of the I-gel can easily be taught to healthcare
workers in facilities in low-income countries within the
framework of the Helping Babies Breathe curriculum. The
neonatal I-gel was superior to the face mask in establishing
effective PPV, and the healthcare workers felt it was easier
to use than the face mask. These manikin data provide a
useful stepping stone for future clinical research on neo-
natal resuscitation with a supraglottic airways device in
low-resource settings.
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AbsTrACT
Objective Mortality rates from birth asphyxia in low-
income countries remain high. Face mask ventilation 
(FMV) performed by midwives is the usual method of 
resuscitating neonates in such settings but may not 
always be effective. The i-gel is a cuffless laryngeal mask 
airway (LMA) that could enhance neonatal resuscitation 
performance. We aimed to compare LMA and face mask 
(FM) during neonatal resuscitation in a low-resource 
setting.
setting Mulago National Referral Hospital, Kampala, 
Uganda.
Design This prospective randomised clinical trial was 
conducted at the labour ward operating theatre. After 
a brief training on LMA and FM use, infants with a 
birth weight >2000 g and requiring positive pressure 
ventilation at birth were randomised to resuscitation by 
LMA or FM. Resuscitations were video recorded.
Main outcome measures Time to spontaneous 
breathing.
results Forty-nine (24 in the LMA and 25 in the FM 
arm) out of 50 enrolled patients were analysed. Baseline 
characteristics were comparable between the two arms. 
Time to spontaneous breathing was shorter in LMA arm 
than in FM arm (mean 153 s (SD±59) vs 216 s (SD±92)). 
All resuscitations were effective in LMA arm, whereas 11 
patients receiving FM were converted to LMA because 
response to FMV was unsatisfactory. There were no 
adverse effects.
Conclusion A cuffless LMA was more effective than FM 
in reducing time to spontaneous breathing. LMA seems 
to be safe and effective in clinical practice after a short 
training programme. Its potential benefits on long-term 
outcomes need to be assessed in a larger trial.
Clinical trial registry This trial was registered in 
https:// clinicaltrials. gov, with registration number 
NCT02042118.
InTrODuCTIOn
Each year, intrapartum-related complications 
(birth asphyxia) result in 1.2 million stillbirths, 
700 000 term newborn deaths and an estimated 
1.2 million babies developing neonatal encephalop-
athy (previously called hypoxic ischaemic enceph-
alopathy).1 2 Of these, 96% occur in low-income 
and middle-income countries.3 4 Successful resus-
citation could prevent a large proportion of these 
deaths and improve the outcomes of neonates 
surviving asphyxia.3 5 6 Therefore, all birth atten-
dants, including physicians, midwives and nurses 
ought to have the knowledge and skills required to 
perform neonatal resuscitation.7 Providing effec-
tive positive pressure ventilation (PPV) is the single 
most important component of successful neonatal 
resuscitation.7 Ventilation is routinely initiated with 
face mask (FM) followed by endotracheal intuba-
tion in case of face mask ventilation (FMV) failure 
or need for prolonged ventilatory support. Endotra-
cheal intubation is the most difficult skill to master 
in neonatal resuscitation and mostly properly 
performed only by experienced physicians.8 Mask 
leakage, airway blockage and poor chest expansion 
have been reported during FMV.9 The American 
Heart Association and the European Resuscitation 
Council Guidelines have proposed to use the laryn-
geal mask either as a primary device, replacing FM 
if ventilation is ineffective, or as an alternative to 
intubation during resuscitation of the late-preterm 
and term newborns (>34 weeks gestation and/
or birth weight >2000 g).10 Several publications 
including a Cochrane review have shown that the 
laryngeal mask allowed effective PPV in most of the 
treated patients (range 95%–99%)11–14 reducing the 
need for intubation.15 In previous studies, a classic 
inflatable size 1 laryngeal mask was used.11 12 15 16 
The i-gel size 1 is a new model of cuffless laryn-
geal mask airway (LMA), also described as a supra-
glottic airway, that has recently been made available 
for newborns (2–5 kg). It is designed to provide an 
What is already known on this topic?
 ► Birth asphyxia contributes to almost 1 million 
neonatal deaths.
 ► Positive pressure ventilation is the most 
important component of successful neonatal 
resuscitation.
 ► Ventilation with face mask (FM) is a difficult 
skill to master, particularly in low-income 
settings.
What this study adds?
 ► A cuffless laryngeal mask airway (LMA) reduced 
time to spontaneous breathing compared 
with FM during newborn resuscitation in a 
low-resource setting.
 ► LMA is effective and easy to use after a short-
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efficient seal to the larynx without an inflatable cuff. Positioning 
is easy with a low risk of tissue compression or dislodgement.17 
All these characteristics make the cuffless LMA a potentially 
useful alternative to FM and endotracheal intubation, especially 
in settings where the staff skills in performing PPV are insuffi-
cient.15 In a previous manikin study conducted in a low-resource 
setting, we found that the LMA was more effective than FM in 
establishing PPV,18 but there are no published randomised trials 
comparing the LMA with the FM during neonatal resuscitation.
The aim of the current trial was to determine if the LMA can 
reduce the time to spontaneous breathing of newborns needing 
PPV in a large delivery ward, where resuscitation is mainly 
performed by midwives. The safety of the intervention was deter-
mined by the assessment of clinical outcomes and side effects.
PATIenTs AnD MeThODs
setting
This was a phase II, single-centre, prospective, open-label, 
randomised controlled trial (RCT) conducted at the Depart-
ment of Obstetrics and Gynaecology, Mulago National Referral 
Hospital in Kampala, Uganda, where about 33 000 deliveries 
occur every year. Due to local organisational aspects, the trial 
was conducted at the operating theatre where 15–30 caesarean 
sections, most of them on emergency basis, are performed each 
day.
Inborn infants satisfying the following inclusion criteria were 
eligible to participate in the trial: gestational age >34 weeks 
by best obstetric estimate (last menstrual period or ultrasound 
scan), expected birth weight >2000 g, need for PPV at birth and 
written parental consent. Exclusion criteria included presence of 
major malformations.
recruitment and implementation
Participants were recruited in the operating theatre among 
mothers awaiting caesarean section because of fetal distress. The 
bilingual consent form was given to mothers assessed by a doctor 
from the obstetric department, proficient in Luganda, the most 
common local language in the Kampala region. Recruitment 
took place only daytime on days when a supervisor available to 
oversee resuscitations (figure 1). This safety requirement delayed 
the completion of the study.
Training
Before the trial, all the staff involved in neonatal resuscitation 
participated in a Helping Babies Breathe (HBB) refresher course 
(version 1). All participants had previously attended at least one 
course on neonatal resuscitation. Two certified instructors in 
neonatal resuscitation held the course. It consisted in a review 
of the HBB action plan and practical hands-on skill stations. The 
training included simulation scenarios involving key procedures 
of the action plan (thermal loss prevention, stimulation, clinical 
assessment, airway management and so on) and the use of the 
FM (Laerdal silicon resuscitator, Laerdal Medical, Stavanger, 
Norway). The HBB course does not include chest compressions 
and medications. An additional module for training on the use 
of the i-gel (Intersurgical, Wokingham, Berkshire, UK) LMA 
was added. A high-fidelity model (SimNewB Laerdal manikin, 
Laerdal Medical) was used to train the staff in the use of both 
devices (LMA and FM). It provides realistic airways and good 
feedback with chest rise when effective PPV is provided. The 
staff learnt an insertion technique that is similar in the manikin 
compared with the newborn. A silicon lubricant facilitated the 
procedure (not needed in the newborn due to oral secretions). 
The LMA was placed with the outlet facing towards the chin of 
the baby with the head maintained in a neutral position. The 
chin was pressed down to open the mouth while the soft tip 
got inserted into the mouth towards the hard palate. The device 
was further inserted downward along the hard palate until the 
tip met a definite resistance. If the cuff was correctly located 
against the laryngeal inlet, PPV resulted in chest rise. FMV was 
taught according to the HBB curriculum. In case of failed FMV, 
the participants were instructed to apply following corrective 
measures before considering the alternative airway: reapplica-
tion of the mask, repositioning of the head and increase of the 
inspiratory pressure. The use of suction was de-emphasised. 
Twenty-eight participants (13 midwives or anaesthetist nurses 
and 15 physicians) were trained. A minimum of three successful 
LMA insertions and three FMV performances in the manikin 
were required of all participants before starting the trial. All staff 
participating in the study had received similar HBB neonatal 
resuscitation training prior to the course.
Intervention
All neonates were cared for in accordance with the updated 
Mulago Hospital neonatal resuscitation flow chart based on HBB 
(version 1). All resuscitations were performed by health staff 
under supervision of instructors who could provide corrective 
measures, if needed. The HBB principle of the Golden Minute 
was applied and included drying, stimulation and, if necessary, 
clearing the airways of the baby with a bulb suction device. 
Heart rate (HR) was assessed at 60, 90, 180 and 240 s. PPV with 
LMA or FM was initiated in case of apnoea and/or gasping and/
or HR <100 bpm at 1 min of life. PPV was administered with 
a 240 mL silicon self-inflating bag with a pop-off valve limit at 
35 cm H2O (Laerdal Medical). Silicone, round-shaped FM (size 
1, Laerdal Medical) and i-gel LMA (size 1) were available at 
each delivery (figure 2). Babies that failed on the assigned device 
(LMA or FM) were converted to the alternative device (LMA 
or FM). Failure was defined as poor HR response and/or lack 
of chest rise. Manual ventilation was initiated in room air at a 
frequency of 40–60 breaths per minute. Endotracheal intuba-
tion is not possible in this setting. All babies with 5 min Apgar 
score <5, respiratory distress, hypothermia (axillary tempera-
ture <36.0°C) or signs of encephalopathy were transferred to 
the neonatal special care unit.
Data collection
All resuscitations were recorded on audio-enabled video using 
a waterproof Lumix DMC-FT5 HD camera (Panasonic, Osaka, 
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Japan) attached to a mount on the resuscitation table. Recording 
started manually at time of birth and stopped at the end of the 
resuscitation procedure. The baby, the health providers’ hands 
and the tablet for data recording were continuously filmed with 
narrow field of view. This allowed precise assessment of time 
to spontaneous breathing, assistance by supervisor and conver-
sion to alternative device by trial arm. The HR of the patient 
was collected using the NeoTap app (www. Tap4Life. org), a 
newly developed mHealth software for Android and IOS mobile 
devices. HR was obtained by advanced users (NJP and CL) 
auscultating the heart and simultaneously tapping the screen for 
three beats. HR data at 30 and 60 s after birth are not possible 
with current pulse oximetry technology.
Three research assistants recorded perinatal data postop-
eratively in an Excel database (Microsoft Corp, Redmond, 
Washington). The video data were reviewed separately by two 
investigators. Non-matching data were reviewed by a third 
investigator.
Outcomes
Primary outcome was the time to spontaneous breathing 
defined as the sum of time elapsed from birth to initiating PPV 
and the ventilation time. Secondary outcomes were admis-
sion to neonatal unit in the first 48 hours of life, hypoxic isch-
aemic encephalopathy, death and adverse effects secondary to 
the procedure (vomiting, bleeding or laryngospasm). HR was 
added as an outcome because a non-invasive method was made 
available.
sample size
In accordance with a previous study on this topic,15 we expected 
a longer time to spontaneous breathing with FM than with 
LMA. Moreover, we estimated time to spontaneous breathing 
to be longer in our sample because of delays in delivery and 
difficulties in assessing fetal distress at Mulago Hospital. Time to 
spontaneous breathing was modelled with gamma distribution 
as right-skewed data of duration.19 In accordance with local clin-
ical observations and available information in a similar setting, 
we hypothesised a mean time to spontaneous breathing of 210 s 
(with shape parameter k 5.3) with FM and of 150 s (with shape 
parameter k 6.8) with LMA.15 With a power of 0.80 and a type 
I error of 0.05, the sample size was estimated in 23 subjects per 
arm, for a total of 46 subjects.20 This number was increased by 
10% to cater for post hoc exclusions, thus we planned to enrol 
50 subjects. This sample size was also considered appropriate for 
a task-shifting trial emphasising safety aspects when involving 
midwives for the first time in advanced airway management.
random assignment
Each newborn was randomised at birth using a small opaque 
plastic container concealing 25 white and 25 black toothpicks. 
The colour of the randomly plucked toothpick determined if 
LMA or FM would be used. If the baby needed resuscitation, 
the toothpick would be broken and removed from the container. 
If not, it was put back into the container. This randomisation 
method was found appropriate for a low-resource context with 
limited space and power availability.
statistical analysis
Categorical data were expressed as number and percentage and 
were compared between the two arms using Fisher’s exact test. 
Birth weight was expressed as median and IQR and compared 
between the two arms using Mann-Whitney test. Duration data 
(time to spontaneous breathing, start of PPV and ventilation 
time) were modelled with gamma distribution, which is often 
used to model the time required to perform some procedures. 
In fact, the gamma distribution is bounded on the left at zero, 
thus excluding negative values (and negative duration data are 
impossible). The gamma distribution is also positively skewed, 
meaning that it has an extended tail to the right of the distri-
bution. This allows a non-zero probability of very long time 
required to perform the procedure, even though the typical time 
to perform the procedure may not be very long. Observed dura-
tion data were summarised as mean and SD. The effect of the 
device (LMA and FM) on duration data was assessed using a 
gamma model. HR was recorded at different time points during 
the trial and was expressed as mean and SD. A linear mixed 
effect models was used to assess the effect of the device on HR, 
accounting for the longitudinal structure of the data. A p value 
less than 0.05 was considered statistically significant. Statistical 
analysis was performed using R V.3.2.2 software (R Foundation 
for Statistical Computing, Vienna, Austria).21
ethical considerations
The protocol was approved by the Institutional Review Board 
of Mulago National Referral Hospital, the Uganda National 
Council of Science and Technology, the National Drug Authority 
and by the Regional Committee for Medical Research Ethics of 
Southern Norway, Section D in Norway.
The i-gel LMAs were purchased for the study without corpo-
rate sponsorship.
Written and oral information was obtained from the parent(s) 
on maternal admission, and a senior investigator was available 
to discuss any questions regarding the trial. Informed written 
consent was signed by a parent or caregiver before admission to 
the operating room.
resulTs
Fifty patients (25 LMA and 25 FM) were enrolled in 2014 from 
April 24 to August 5. The trial was ended on August 7 after 
the last completed follow-up. One patient in the LMA arm was 
excluded after resuscitation due to congenital cardiac malfor-
mation, thus the final sample included 49 patients (figure 1). 
All patients were delivered by emergency caesarean section. 
Maternal and neonatal characteristics were comparable in the 
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two arms (table 1). Accurate gestational age was unavailable for 
most patients.
Forty-two resuscitations (86%) were performed by midwives 
(21 in FM group and 21 in LMA group), while the remaining 7 
(14%) by physicians (three in FM group and four in LMA group). 
Information on the procedure is shown in table 2. Overall, PPV 
started after a mean of 64 s (60 s in LMA arm and 68 s in FM 
arm; p=0.26). Total ventilation time was shorter in LMA arm 
than in FM arm (mean 93 s vs 140 s, p=0.02). Assistance from 
the supervising physician was required in nine procedures (three 
in LMA arm and six in FM arm; p=0.46). Incorrect FM position 
(n=4) had an impact on PPV prior to repositioning. Misplaced 
LMA (n=1) that could lead to potential side effect was verbally 
corrected in one instance before insertion. All procedures were 
effective in the LMA arm, whereas 11 patients receiving FM 
were converted to LMA after 150 s because response to FMV was 
deemed unsatisfactory by the supervisor (p=0.0002) because of 
poor HR response and/or lack of chest rise.
Mean time to spontaneous breathing was 153 s (SD 59) with 
LMA and 216 s (SD 92) with FM (p=0.005; table 3). The model 
estimated a mean reduction of 31% (95% CI 11% to 44%) in 
time to spontaneous breathing with LMA. The outcome in the 
first 48 hours of life was similar in the two arms (table 3). Thir-
teen patients needed admission to the neonatal unit (five in LMA 
arm and eight in FM arm), two patients in FM arm suffered 
hypoxic ischaemic encephalopathy and one patient in FM arm 
died within the first 48 hours of life. There were no adverse 
effects of the LMA such as laryngospasm, bleeding or vomiting.
HR increased during the first 240 s of life (p<0.0001) and 
was higher in LMA arm than in FM arm (p=0.0006), but the 
rate of increase was similar in the two arms (p=0.48) (figure 3 
and  online supplementary table 1). The proportion of patients 
with HR <100 bpm decreased in both arms from about 80% at 
30 s after birth to 4% at 240 s after birth.
DIsCussIOn
The most relevant results of this small phase II trial include (A) 
time to spontaneous breathing and total ventilation time were 
significantly shorter in the LMA arm than in FM arm; (B) almost 
half (44%) of the neonates who did not respond to FMV were 
successfully rescued with the LMA; (C) use of neonatal LMA was 
safe, even in the hands of inexperienced health staff.
A few observational studies and RCTs have evaluated the use 
of cuffed laryngeal masks during neonatal resuscitation and have 
unanimously concluded that laryngeal mask allowed effective 
PPV in most of the treated patients (range 95%–99%).11 13 14 One 
quasirandomised study showed that successful resuscitation with 
the laryngeal mask was significantly higher, and the total ventila-
tion time with the laryngeal mask was significantly shorter than 
with FMV. The authors concluded: ‘the laryngeal mask is safe, 
effective and easy to implement for the resuscitation of neonates 
with a gestational age of 34 or more weeks’.15 Another recent 
study from Vietnam confirmed that a new neonatal laryngeal 
mask (Supreme-LMA) was more effective than FM in preventing 
endotracheal intubation in newborns needing PPV at birth.22 All 
these studies were conducted by using a cuffed laryngeal mask.23 
Our findings add that a cuffless supraglottic airway is also more 
effective than an FM in achieving a rapid recovery of neonates in 
need of PPV at birth. The innovative design of the LMA simpli-
fies positioning and should be well suited for clinical settings 
lacking staff experienced in airway management.
Training of staff involved in neonatal resuscitation has been 
identified as a crucial factor in reducing neonatal mortality. The 
Table 1 Baseline maternal and neonatal characteristics by trial arm
lMA (intervention) n=24 n (%) Face mask (comparator) n=25 n (%) p Value
Caesarean section 24 (100) 25 (100) –
Primiparous 9 (38) 9 (36) 0.99
(Pre-) Eclampsia 0 3 (12) 0.23
Placenta abruption 0 2 (8) 0.49
Oligohydramnios 2 (8) 1 (4) 0.61
Foul smell 3 (13) 4 (16) 0.99
Meconium stained 10 (42) 13 (52) 0.57
Male gender 13 (54) 13 (52) 0.99
Median (IQR) Median (IQR)
Gestational age (weeks) Not available Not available –
Birth weight (gram) 3100 (2962–3478) 2700 (2520–3400) 0.13
Apgar score 1 min 4 (3–5) 4 (3–5) 0.73
Apgar score 5 min 8 (7–9) 7 (6–9) 0.26
Apgar score 10 min 10 (9-10) 9 (8–10) 0.17
Table 2 Time to start of ventilation, ventilation time, assistance by supervisor and conversion to alternative device by trial arm
lMA (intervention) n=24 Mean (sD)
Face mask 
(comparator) n=25 Mean (sD) p Value
effect of the intervention Mean 
ratio (95% CI)
Start of PPV (s) 60 (11) 68 (36) 0.26 0.88 (0.70 to 1.10)
Ventilation time (s) 93 (52) 140 (90) 0.02 0.67 (0.47 to 0.93)
n (%) n (%) OR (95% CI)
Assistance from the supervising physician 3 (13) 6 (24) 0.46 0.46 (0.07 to 2.52)
Conversion to alternative device 0 11 (44) 0.0002 0.00 (0.00 to 0.29)
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meta-analysis of existing studies suggests that neonatal resusci-
tation training in facilities is associated with a 30% reduction 
in intrapartum-related neonatal mortality.24 Low-intensity 
high-frequency training programme are essential for maintaining 
skills and proper clinical practice.6 25 26 FMV is an essential part 
of this training, but reaching and maintaining adequate perfor-
mance represent a continuous challenge for both experienced 
and inexperienced caregivers.25
Task-shifting the use of supraglottic airways to non-doctor 
or inexperienced health staff in rural areas could be one way 
to improve the current situation. In agreement with previous 
studies,15 22 our data suggest that the learning curve to reach 
adequate proficiency in the use of supraglottic airways is steep. 
Ventilation with LMA can also be performed using one hand 
only. This may be crucial in remote setting where birth atten-
dants typically work alone and may need to resuscitate the baby 
by the mother.
Video-recording allowed precise and objective assessment of 
the primary outcome. The camera was manually operated by the 
supervisor. This led to a minor disturbance around the resusci-
tation table. Once started, the camera did not seem to interfere 
with clinical activity. The overall impression was that video-re-
cording was well accepted by local staff. The potential use of the 
video for feedback and training was beyond the scope of this 
trial but is appealing and as has been used mostly in high-income 
settings.9 27
There are some limitations in this RCT. First, it was a phase 
II trial, so only a limited number of patients were included. 
Second, it was open-label as no masking or blinding is possible in 
this type of trial. Third, health caregivers responsible for resus-
citation were under supervision of a trained person potentially 
influencing the procedure, but this was similar for both arms. 
Additional data such as accurate gestational age, signs of fetal 
distress, blood gases and oxygen saturation were not available 
in this low-income setting. HR was instead obtained with an 
mHealth tool (www. tap4life. org).
Earlier studies have assessed cuffed laryngeal masks during 
neonatal resuscitation in high-income and middle-income 
settings with experienced staff. This trial assesses the efficacy and 
safety of a cuffless supraglottic airway in the hands of staff inex-
perienced in administrating PPV at birth after a short training 
programme in a low resource setting.
COnClusIOn
Mastering PPV during newborn resuscitation is a difficult skill. A 
cuffless LMA reduced the time to spontaneous breathing during 
newborn resuscitation compared with FM. The LMA seems to 
be safe and effective in a low-income setting after a short training 
programme.
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Table 3 Primary and secondary outcomes by trial arm
lMA (intervention)
n=24 mean (sD) range
Face mask (comparator)
n=25 mean (sD) range p Value
effect of the intervention
Mean ratio (95% CI)
Primary outcome 0.005 0.70 (0.56 to 0.89)




n (%) n (%) OR (95% CI)
Secondary outcomes
  Admission to neonatal unit (first 48 hours) 5 (21) 8 (32) 0.52 0.56 (0.12 to 2.42)
  Neonatal encephalopathy 0 2 (8) 0.49 0.00 (0.00 to 5.51)
  Death within 48 hours 0 1 (4) 0.99 0.00 (0.00 to 40.63)
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Neonatal resuscitation using a supraglottic
airway device for improved mortality and
morbidity outcomes in a low-income
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trial
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Abstract
Background: Intrapartum-related death is the third leading cause of under-5 mortality. Effective ventilation during
neonatal resuscitation has the potential to reduce 40% of these deaths. Face-mask ventilation performed by
midwives is globally the most common method of resuscitating neonates. It requires considerable operator skills
and continuous training because of its complexity. The i-gel® is a cuffless supraglottic airway which is easy to insert
and provides an efficient seal that prevents air leakage; it has the potential to enhance performance in neonatal
resuscitation. A pilot study in Uganda demonstrated that midwives could safely resuscitate newborns with the i-gel®
after a short training session. The aim of the present trial is to investigate whether the use of a cuffless supraglottic
airway device compared with face-mask ventilation during neonatal resuscitation can reduce mortality and
morbidity in asphyxiated neonates.
Methods: A randomized phase III open-label superiority controlled clinical trial will be conducted at Mulago
Hospital, Kampala, Uganda, in asphyxiated neonates in the delivery units. Prior to the intervention, health staff
performing resuscitation will receive training in accordance with the Helping Babies Breathe curriculum with a
special module for training on supraglottic airway insertion. A total of 1150 to 1240 babies (depending on cluster
size) that need positive pressure ventilation and that have an expected gestational age of more than 34 weeks and
an expected birth weight of more than 2000 g will be ventilated by daily unmasked randomization with a supraglottic
airway device (i-gel®) (intervention group) or with a face mask (control group). The primary outcome will be a composite
outcome of 7-day mortality and admission to neonatal intensive care unit (NICU) with neonatal encephalopathy.
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Discussion: Although indications for the beneficial effect of a supraglottic airway device in the context of neonatal
resuscitation exist, so far no large studies powered to assess mortality and morbidity have been carried out. We
hypothesize that effective ventilation will be easier to achieve with a supraglottic airway device than with a face mask,
decreasing early neonatal mortality and brain injury from neonatal encephalopathy. The findings of this trial will be
important for low and middle-resource settings where the majority of intrapartum-related events occur.
Trial registration: ClinicalTrials.gov. Identifier: NCT03133572. Registered April 28, 2017.
Keywords: Global health, Low-income country, Laryngeal mask, Supraglottic airway device, Positive pressure ventilation,
Newborn infant, Resuscitation, Neonatal mortality, Asphyxia, Asphyxia neonatorum, Intrapartum-related complications
Background
Problem statement
Since 2015, after Millennium Development Goal num-
ber 4 (MDG-4), of globally reducing by two thirds
the under-5 (years of age) mortality, was summarized,
it has become evident that neonatal mortality does
not decrease at the same pace as post-neonatal mor-
tality [1].
Of the 140 million babies born in the world annually,
7–9 million will need resuscitation at birth. The latest
estimates are that 662,000 deaths annually are caused by
intrapartum-related events, commonly referred to as
birth asphyxia, which is the third leading cause of
under-5 mortality globally [2].
Key health indicators from Uganda in 2017 show that
child (under-5) mortality decreased from 175 out of 1000
in 1990 to 53 out of 1000 in 2016 [3]. The rate of neonatal
mortality, however, is estimated at 27 out of 1000 and re-
mains unchanged despite the national roll-out of pro-
grams such as Helping Baby Breathe (HBB) [3, 4], a basic
neonatal resuscitation curriculum for resource-limited set-
tings aiming at improving skilled attendance at birth [5].
HBB implementation trials have demonstrated a reduction
in fresh stillbirths and first-day neonatal mortality. How-
ever, recent studies in India, Kenya, and Nepal assessing
long-term outcomes showed no change in overall 28-day
neonatal mortality or perinatal mortality [6, 7].
Sustainable Development Goal number 3 (SDG-3) re-
emphasizes the need of accelerating the reduction of
neonatal mortality; each country should aim for a neo-
natal mortality below 12 out of 1000 live births by 2030.
Achieving this goal will be possible only if we improve
existing neonatal resuscitation programs [8]. All birth at-
tendants, including physicians, midwives, and nurses,
should have the knowledge and skills required to per-
form effective neonatal resuscitation [9]. Innovative tools
that can strengthen existing strategies will have to be
rapidly implemented if we are to reach the 12 out of
1000 target of neonatal death by 2030.
Rationale
Providing positive pressure ventilation (PPV) is the sin-
gle most important component of successful neonatal
resuscitation [8, 9]. Yet the mortality of newborns need-
ing face mask (FM) ventilation was as high as 10% in
Tanzania [10].
Effective ventilation during neonatal resuscitation has
the potential to reduce 40% of intrapartum-related
deaths [11]. However, the delivery of proper tidal volume
is a difficult technique to master. Mask leakage, airway
blockage, and poor chest expansion have been reported
during FM ventilation [12–14].
Ventilation is routinely initiated with FM followed by
endotracheal intubation in case of FM ventilation failure
or need for prolonged ventilatory support. Endotracheal
intubation is the most difficult skill to master in neo-
natal resuscitation and performed only by experienced
physicians [15]. The use of endotracheal tube (ETT) is
not included in resuscitation guidelines aimed at low-
resource settings [16].
The American Heart Association and the European
Resuscitation Council guidelines have proposed the use
of the laryngeal mask airway (LMA) to replace FM if
ventilation is ineffective or as an alternative to ETT dur-
ing resuscitation of the late-preterm and term infants (at
least 34 weeks’ gestation or birth weight of more than
2000 g or both) if intubation is unsuccessful [17].
Several publications, including a recent Cochrane re-
view [18, 19], have shown that the LMA allowed effect-
ive PPV in most of the treated patients (range of 95–
99%) [20–24], reducing the need for intubation [25, 26].
In previous studies, an inflatable size 1 laryngeal mask
was used [21, 23–27].
The i-gel® (Intersurgical Ltd., Wokingham, Berkshire,
UK) size 1 is a new model of cuffless supraglottic airway
device that has recently been made available for new-
borns (2–5 kg). It is designed to provide an efficient seal
to the larynx without the inflatable cuff used in the trad-
itional LMA. Positioning is easy with a low risk of tissue
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compression or dislodgement [28–30]. All of these char-
acteristics make the i-gel® a potentially useful alternative
to FM and ETT, especially in settings where the staff
skills in performing PPV are insufficient [25–27]. A pro-
spective observational study of 50 children demonstrated
a success ratio of 100% for the insertion of the i-gel®. All
devices were inserted on the first attempt. The study
showed very few complications and concluded that it
seems to be a safe and efficient device for pediatric air-
way management [31].
Task shifting the use of a cuffless supraglottic airway
device to non-doctor or inexperienced health staff in
resource-limited settings could be one way to improve
outcome following newborn resuscitation. A manikin
study in Uganda demonstrated that midwives could eas-
ily insert a cuffless supraglottic airway after brief on-the-
job training: the i-gel® was also more effective than FM
in establishing PPV in the manikin. In 2015, a phase II
randomized controlled trial (RCT) on the same site
demonstrated that midwives could effectively and safely
perform resuscitation in neonates with the i-gel® [32, 33].
The effectiveness and safety of a supraglottic airway
device compared with FM, as the primary interface for
newborn resuscitation, are still identified as important
knowledge gaps. The critical outcomes of mortality and
indicators of brain damage also need to be assessed [34].
The proposed trial will follow the SPIRIT (Standard
Protocol Items: Recommendations for Interventional
Trials) guidelines [35] and provide evidence to deter-
mine whether use of a supraglottic airway device trans-
lates into better clinical outcomes and thus can be
considered part of future guidelines for neonatal resusci-
tation in resource-limited settings (Additional file 1).
The aim of the present trial will be to compare the ef-
fectiveness of two interfaces (i-gel® versus FM) for ad-




A randomized phase III open-label superiority controlled
clinical trial will be conducted in neonates needing PPV
at birth with two parallel groups (1:1 ratio): resuscitation
with a supraglottic airway device (i-gel®) compared to
FM (standard of care).
Setting
This trial will be conducted in Uganda at the Delivery
Unit and Operating Theatre of the Department of Ob-
stetrics and Gynaecology at Mulago National Referral
Hospital, Kampala, which has about 25,000 annual
deliveries.
Inclusion criteria
Inborn infants fulfilling the following inclusion criteria
will be eligible to participate in the trial:
 Inborn baby (i.e., born in the hospital)
 Estimated gestational age of at least 34 weeks
 Estimated birth weight of at least 2000 g
 Need for PPV at birth (based on HBB algorithm)
 Parental consent.
Exclusion criteria
 Major malformations (incompatible with sustained
life or affecting the airways)
 Macerated stillbirth.
Primary outcome measures
 A composite outcome of (a) 7-day mortality or (b) ad-
mission to neonatal intensive care unit (NICU) with
neonatal encephalopathy (maximum Thompson score
of 11 or above at day 1–5 during hospitalization) or
both [36–38].
Secondary outcome measures
 Safety of i-gel® in the hands of lower cadre (non-doc-
tor) birth attendants: adverse events (AEs) and serious
adverse events (SAEs)
 Time to initiate PPV
 Heart rate at 0, 60, 90, 120, 180, 240, and 300 s
 Advanced resuscitation (chest compressions,
intubation, and drug delivery), including
intervention by supervising physician
 Early neonatal death (<7 days)
 Very early neonatal death (<24 h)
 Neonatal encephalopathy: admission to NICU with a
Thompson score of 11 or above during day 1–5
during hospitalization
 Neonatal encephalopathy: admission to NICU with a
Thompson score of 7 or above at day 1–5 during
hospitalization
 Any hospital admission during the first 7 days of life.
Procedures
Prior to interventions: training midwives
Two hundred members of the staff involved in neo-
natal resuscitation participated in a modified HBB
(2nd edition) one-day course [5] during two weeks in
November 2017. The course was held by two pedia-
tricians familiar with the use of supraglottic airway
devices and was facilitated by two or three local HBB
instructors. It consisted of a review of the HBB action
plan and practical hands-on skill stations. The HBB
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training includes simulation scenarios involving key
procedures of the action plan (thermal loss preven-
tion, stimulation, clinical assessment, airway manage-
ment, etc.) and the use of the FM (Laerdal silicon
resuscitator, Laerdal Medical, Stavanger, Norway). An
additional module for training on the use of the i-gel®
(Intersurgical Ltd.) was added. A high-fidelity model
(SimNewB Laerdal manikin, Laerdal Medical) was
used to train the staff in the use of both devices (i-
gel® and FM). SimNewB provides realistic airways and
good feedback with chest rise when effective PPV is
provided. The participants learned the insertion tech-
nique recommended by the manufacturer that is the
same in the manikin and in the neonate [26, 32]. A
silicon lubricant (not needed in newborn infants be-
cause of oral secretions) facilitated the procedure.
Three successful i-gel® insertions in the manikin were
required to partake in the study. FM ventilation was
taught in accordance with the HBB curriculum using
the NeoNatalie manikin (Laerdal Medical) and in-
cluded advanced corrective measures. In case of failed
FM ventilation, the participants were instructed to
apply the following measures before considering the alter-
native airway device: reapplication of the mask, reposi-
tioning of the head, and increase of the inspiratory
pressure. The use of suctioning was de-emphasized in ac-
cordance with the latest guidelines.
Recruitment and implementation
Investigators and trained research assistants will partici-
pate in the enrollment of participants in accordance with
the inclusion criteria (Fig. 1). Neonates will be recruited
every day around the clock consecutively until sample
size is reached. Data from babies will be used in the trial
only after written parental consent is given. A senior in-
vestigator will be available at all times to discuss con-
cerns raised by parents or clinicians during the course of
the trial.
Tagging of newborns
All neonates enrolled in the trial and their mothers will
be tagged with a trial bracelet with a unique trial ID
number to facilitate matching and retrieval.
Fig. 1 Trial profile (CONSORT flowchart)
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Randomization
Cluster randomization will be used, choosing day-by-day
clusters. For practical reasons, individual randomization
is not feasible, so all neonates enrolled in the same day
(representing a cluster) will be randomly assigned to the
same treatment. This approach randomly assigns daily
groups of neonates rather than individual neonates, and
neonates within any one day are likely to respond in a
similar manner; hence, their data cannot be assumed to
be independent. The clustering structure of the data was
taken into account in sample size calculation and data
analysis planning. A randomization list will be made by
an independent statistician using block randomization
with block sizes of 4–8. The allocation remains con-
cealed until the actual trial day when the randomization
envelope is opened by the surveillance officer on duty at
8 a.m. The midwives are informed at the beginning of
each shift of the assigned treatment. The envelopes and
assignment cards are discarded after use. The assigned
procedure will then be performed until the next
randomization. To provide proper PPV to the baby, the
American Heart Association and European Resuscitation
Council guidelines recommend switching to a supraglot-
tic airway device if the resuscitator considers that the
FM is failing [17]. We recommend the resuscitator to
optimize the ventilation during 3 mins before consider-
ing switching ventilation option from FM to i-gel and
vice versa, to keep contamination between arms low.
The intervention
Oral consent will be sought for all mothers admitted to
the delivery unit, followed by deferred written informed
consent as soon as practicable for mothers of babies eli-
gible for the trial. HBB principles of the golden minute
will be applied to all babies not crying at birth, including
drying, stimulation, and assessment. A stopwatch will be
started at the time of birth by a research assistant for all
eligible participants. In the case of “baby is not breath-
ing” after initial steps, the midwife will immediately
(after cutting the cord) move the babies in need of PPV
to the resuscitation area. Inflations will be administered
with room air at a rate of 40 to 60/min with a 240-mL
silicon self-inflating bag and a pop-off valve limit at 35
cm H2O (Laerdal Medical). Silicone, round-shaped FM
(size 1, Laerdal Medical) or i-gel® (size 1) will be available
at each delivery. The duration of resuscitation will be de-
fined as the time period from start of ventilation to the
establishment of spontaneous breathing. Heart rate will
be registered with a dry-electrode electrocardiogram
monitor (NeoBeat Newborn Heart Meter, Laerdal Global
Health, Stavanger Norway) featuring fast signal acquisi-
tion [39]. All babies with a 5-min APGAR (Appearance,
Pulse, Grimace, Activity and Respiration) score of less
than 7, respiratory distress, hypothermia (axillary
temperature of less than 36.0 °C), or signs of encephal-
opathy will be transferred to the NICU. Resuscitation
data, any contamination between arms, follow-up con-
tact, and admission to the neonatal unit will be recorded
by a research assistant. All interventions will be recorded
on video to ensure quality assurance and data collection.
Management from supervising physician
Advanced resuscitation can be initiated in accordance
with local hospital and International Liaison Committee
on Resuscitation (ILCOR) guidelines [34], should a
supervising physician be available. This can include use
of alternative airways, including ETT, chest compres-
sions, and drug administration.
Contamination between arms
Contamination between arms (switching to the alterna-
tive device) will be possible after 3 min of sustained PPV,
should ventilation be deemed unsatisfactory. The alter-
native device will be accessible in an easily accessible
box on the resuscitation table. This possible scenario will
be practiced during the training. In all cases, a report
specifying the reasons for switching to the alternative
airway device will be filled out.
Masking
Health-care providers (midwives) performing resuscita-
tion and the research assistant recording resuscitation
data in the delivery ward cannot be masked to the allo-
cation arm. However, the examiners assessing neonatal
encephalopathy outcomes will be masked to the arm al-
location. Outcome examiners will be exclusively working
at the NICU, physically separated from where the resus-
citations are performed. The arm allocation will not
appear on the medical chart. Thus, arm allocation of ad-
mitted patients will not be identifiable by the outcome
examiner. The independent data monitoring committee
(IDMC) will have access to arm allocation when per-
forming interim analysis and assessment of AEs/SAEs.
The statistician who will perform data analysis will be
masked to treatment allocation.
Sample size
Considering our previous phase II trial, we estimate that
a reduction of 25% of adverse outcomes may be possible.
A sample size of 954 participants (477 per arm) is
required to have a 90% chance of detecting, as signifi-
cant at the 5% level, a decrease in the primary outcome
measure from 40% in the standard-of-care arm to 30%
in the supraglottic-airway arm. The sample size is
increased to 1150 or 1240 because of the day-by-day
cluster randomization, assuming an intra-class correl-
ation of 0.10 and an average daily enrollment of three or
four participants, respectively.
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Data collection and monitoring
Assessment and collection of outcomes
The primary outcome will be assessed in two parts. Mor-
tality outcome will be collected daily at the NICU for
admitted trial patients until day 7. Non-hospitalized par-
ticipants will receive a scheduled appointment or phone
call by a trial nurse with the mother at day 7 assessing the
health of the baby. For all hospitalized participants, mor-
bidity by neonatal encephalopathy will be assessed by a
trial doctor masked to the arm allocation. This assessment
will take place daytime on day 1, 2, 3, 4, and 5 or until dis-
charge, using Thompson score (Table 1).
Data from the pre-coded case report form (CRF) will
be entered into Open Data Kit (ODK) (https://opendata-
kit.org), an open-source suite of tools that helps
researchers manage mobile data collection solutions.
The data will be stored on an encrypted server and sub-
sequently transferred to a statistical software package for
analysis.
The CRFs will be pre-tested before the commence-
ment of the trial. Data from the birth attendants’ ques-
tionnaire and the CRFs will be filled in by the birth
attendants and will be continuously entered into ODK.
Videos will be recorded as a quality control. The neo-
natal resuscitation algorithm will be put in place to en-
sure that all interventions are standardized. A proper
light source is needed on the table. Headlamps will act
as backup in case of a power shortage at night.
Independent data monitoring committee
An IDMC consisting of four members—a statistician, an
obstetrician, and two pediatricians—was appointed. They
are operating in accordance with the IDMC charter
which is developed with the members.
The timing of the interim analysis will be carried out
by the IDMC. It will be planned when about half of the
events have occurred, following the DAMOCLES (Data
Monitoring Committees: Lessons, Ethics, Statistics)
group recommendations [40].
The IDMC will ensure that the trial protocol was
followed and control the adequacy of enrollment and
randomization. The interim data will also assess quality
standards and adherence to ethical requirements.
The interim analysis will be performed by the IDMC
statistician unmasked to the treatment allocation. Based
on this, the IDMC will make recommendations on the
continuation of the trial and its modifications or decide
on potential termination in case of harm.
Statistical analysis
A detailed statistical analysis plan—based on the principles
in this section—will be developed before the statistical
analysis of the trial. Data analysis will be performed by
using the statistical software packages Stata, SAS, and R.
All tests will be two-sided, and a P value of less than 0.05
will be considered statistically significant. Missing data will
be considered, and appropriate imputations will be dis-
cussed and performed when appropriate. Statistical ana-
lysis will include an unadjusted analysis followed by an
adjusted analysis. The primary outcome will be compared
between the two treatment arms by using the chi-squared
test. The secondary outcomes will be compared by using
the chi-squared test or Fisher’s test (categorical outcomes)
and using the Student’s t test or Mann–Whitney test
(continuous outcomes). Mixed-effect regression models
will be estimated to evaluate the effect of the treatment on
binary outcomes, adjusting for clusters (random effect)
and clinically relevant confounders. Data analyses will be
performed on an intention-to-treat (ITT) basis. However,
Table 1 Timeline of the trial
Enrollment Allocation Admission neonatal intensive care unit Follow-up
Time point T-1 Day 0 Day 1 Day 2–5 Day 7
Enrollment
Eligibility screen ×






Active monitoring of resuscitation ×
Video recording ×
Neurological status × ×
Mortality assessment × × ×
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since the trial is prone to some contamination (i.e., the
person resuscitating may decide to shift to the other
device) which can be limited by appropriate training but
not entirely prevented, a per-protocol analysis and a
contamination-adjusted ITT analysis will also be per-
formed. These results will be considered along with the
primary ITT analysis when drawing the conclusions of the
trial. Subgroup analyses—per treatment center, time of
the day (i.e., day/night), and per birth mode—will be car-
ried out with exploratory purpose.
Safety
Resuscitations will be continuously monitored by video
and observed by the attending midwife or physician and
the researcher assistant in order to detect AEs and SAEs.
Safety measures will include monitoring of SAEs and de-
tection of unexpected changes in incidence of common
neonatal complications. The AEs will be managed by the
attending hospital physician/midwife/researcher and
followed until resolution or until a stable clinical end-
point is reached by the clinician responsible for the care
of the recruited patient.
If there is a reasonable suspected causal relationship
with the intervention, SAEs will be reported to the Mulago
Research and Ethics Committee (MREC) to guarantee the
safety of the participants. Any suspected unexpected ser-
ious adverse reactions (SUSARs) with or without a reason-
ably plausible causal relationship with use of the
supraglottic airway will also be reported to the MREC.
Ethical considerations
The protocol was approved by the institutional review
board of Mulago National Referral Hospital, Uganda; the
Uganda National Council of Science and Technology;
the Director General from the Ministry of Health,
Uganda (MREC 1168); and the Regional Committee for
Medical and Health Research Ethics (REK South East
reference number 2017/989) in Norway.
Extensive discussions with clinical experts and members
of the ethical board were necessary to solve the problem
of obtaining consent without delaying the intervention. A
two-tier procedure for consent will be implement in this
trial because it involves unexpected care of critically ill
newborns. All mothers entering the labor ward irrespect-
ive of whether their baby is suspected of filling inclusion
criteria will receive brief information of the trial after
which oral consent will be sought. Mothers whose infants
are found eligible at birth will be approached for full writ-
ten deferred consent for continuing participation. All in-
formation, including informed consent and the material
used in the trial, will be translated in English and Luganda
in a clearly understandable form. A senior investigator will
be available to discuss any additional questions regarding
the trial.
Sustainability and scalability
A simplified neonatal resuscitation program that can re-
duce neonatal deaths due to perinatal asphyxia is the
highest newborn global health research priority beyond
2015 [41]. This trial will try to demonstrate the first
phase of scalability of an innovative approach to new-
born resuscitation.
The training module for supraglottic airway use can eas-
ily be integrated to current neonatal resuscitation pro-
grams [33]. The cost-effectiveness of a supraglottic airway
in a low-resource setting needs to be assessed. Such an in-
vestment can be justified only if there is a substantial dif-
ference between the supraglottic airway and FM. We
estimate that a 25% reduction in adverse outcomes is a
clinically significant difference large enough to have policy
implications. A reusable cuffless device is already available
but is still cost-prohibitive [29], so it will be crucial to ex-
plore how the unit cost can be reduced. A historical paral-
lel could be the substantial drop in the cost of anti-
retroviral therapy against HIV over the last decades [42],
allowing scale-up of treatment to a level that previously
seemed impossible in low-resource settings.
Discussion
Newborn resuscitation training and simulation-based cur-
riculum show mixed results in relation to their impact on
newborn mortality [3, 4] and their effect on neurological
morbidity remains unknown [43]. Further improvement
of neonatal resuscitation performance is crucial.
This large trial is the first to assess the impact on mor-
tality/morbidity of the use of a supraglottic airway device
during neonatal resuscitation. It is powered to 90% and
designed to add evidence lacking in this field. To the best
of our knowledge, only four RCTs comparing LMA or
supraglottic airway to FM ventilation including 636 pa-
tients have previously been published [18, 19, 25, 26, 32].
They have focused mainly on vital sign outcomes or suc-
cessful resuscitation [34]. Safety and long-term outcomes
remain important knowledge gaps. This task-shifting
intervention involves midwives as they are the frontline
health workers in many settings where newborn mortality
is high. The burden of disease from intrapartum-related
events can be reduced if simple and robust technologies
for newborn resuscitation can be identified [44].
The trial will also monitor neonatal outcome data until
day 7. We hypothesize that effective ventilation will be
easier to perform with the supraglottic airway device and
significantly decrease early neonatal mortality and brain
damage from neonatal encephalopathy. Results from this
large trial will contribute to provide evidence that can help
define best practice advice for future guidelines.
Trial status
The trial started recruiting participants on May 8, 2018.
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Additional file
Additional file 1: SPIRIT (Standard Protocol Items: Recommendations for
Interventional Trials) guidelines. (DOCX 63 kb)
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